| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 BRAF PKM FGR ALK DDR1 CAMK1D ADCK5 KSR2 LCK CASK EGFR MTOR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 3.31e-13 | 600 | 270 | 35 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 BRAF SPHK1 PKM XYLB FGR ALK DDR1 CAMK1D ADCK5 KSR2 LCK CASK EGFR MTOR PRKAA1 PRKAA2 NT5C2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 4.03e-13 | 709 | 270 | 38 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB4 PRPSAP1 PRPSAP2 CDK17 NMNAT2 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 BRAF SPHK1 PKM XYLB FGR ALK DDR1 CAMK1D ADCK5 POLG KSR2 LCK CASK POLR3B EGFR MTOR GYS2 PRKAA1 PRKAA2 NT5C2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 4.65e-13 | 938 | 270 | 44 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 BRAF SPHK1 PKM XYLB FGR ALK DDR1 CAMK1D ADCK5 KSR2 LCK CASK EGFR MTOR PRKAA1 PRKAA2 NT5C2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 3.89e-12 | 764 | 270 | 38 | GO:0016301 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | EPHB4 EPHA6 SRC JAK3 NEK1 PKM FGR ALK DDR1 LCK EGFR PRKCD HCK EPHA7 EPHB1 | 1.24e-09 | 145 | 270 | 15 | GO:0004713 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 CCT3 MYO5B PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DDX11L8 HSP90AB1 DNAH10 DDX60 ABCB5 IDE MORC2 MLH3 IGHMBP2 SMARCA4 ATP1A4 DDX39A | 8.34e-09 | 441 | 270 | 24 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK17 PSKH1 SPEG MAP3K4 KSR1 NEK1 GRK2 GRK3 BRAF PKM CAMK1D ADCK5 KSR2 CASK EGFR MTOR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 NEK11 | 1.04e-08 | 446 | 270 | 24 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 CCT3 MYO5B PSMC5 CHD3 BCS1L ABCB4 UBA1 MDN1 NAE1 DDX23 DDX60L ABCD1 DNAH8 DDX11L8 HSP90AB1 DNAH10 DDX60 MYO1H ABCB5 IDE MORC2 MLH3 IGHMBP2 SMARCA4 TMEM30A ATP1A4 DDX39A | 2.15e-08 | 614 | 270 | 28 | GO:0140657 |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK17 PSKH1 SPEG MAP3K4 KSR1 NEK1 BRAF CAMK1D KSR2 CASK MTOR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 NEK11 | 5.71e-07 | 363 | 270 | 19 | GO:0106310 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.61e-06 | 46 | 270 | 7 | GO:0004715 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 3.91e-06 | 9 | 270 | 4 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 3.91e-06 | 9 | 270 | 4 | GO:0001640 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA2 CCT3 MYO5B BMS1 PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DDX11L8 HSP90AB1 DNAH10 DDX60 ABCB5 IDE MORC2 GFM2 MLH3 IGHMBP2 SMARCA4 ATP1A4 DDX39A RASD2 | 7.15e-06 | 775 | 270 | 27 | GO:0017111 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 9.68e-06 | 4 | 270 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA2 CCT3 MYO5B BMS1 PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DDX11L8 HSP90AB1 DCPS DNAH10 DDX60 ABCB5 IDE MORC2 GFM2 MLH3 IGHMBP2 SMARCA4 ATP1A4 DDX39A RASD2 | 1.07e-05 | 839 | 270 | 28 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA2 CCT3 MYO5B BMS1 PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DDX11L8 HSP90AB1 DCPS DNAH10 DDX60 ABCB5 IDE MORC2 GFM2 MLH3 IGHMBP2 SMARCA4 ATP1A4 DDX39A RASD2 | 1.09e-05 | 840 | 270 | 28 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA2 CCT3 MYO5B BMS1 PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DDX11L8 HSP90AB1 DCPS DNAH10 DDX60 ABCB5 IDE MORC2 GFM2 MLH3 IGHMBP2 SMARCA4 ATP1A4 DDX39A RASD2 | 1.09e-05 | 840 | 270 | 28 | GO:0016818 |
| GeneOntologyMolecularFunction | calmodulin binding | PDE1C ARPP21 PDE1B MYO5B RYR1 RYR2 RYR3 SPHK1 CAMK1D GRM7 CASK EGFR IQCB1 | 1.60e-05 | 230 | 270 | 13 | GO:0005516 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 2.40e-05 | 5 | 270 | 3 | GO:0099530 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.73e-05 | 65 | 270 | 7 | GO:0004714 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.74e-05 | 6 | 270 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.08e-04 | 19 | 270 | 4 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.54e-04 | 85 | 270 | 7 | GO:0019199 | |
| GeneOntologyMolecularFunction | histone H2BS36 kinase activity | 1.82e-04 | 2 | 270 | 2 | GO:0140823 | |
| GeneOntologyMolecularFunction | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | 1.82e-04 | 2 | 270 | 2 | GO:0047322 | |
| GeneOntologyMolecularFunction | PLC activating G protein-coupled glutamate receptor activity | 1.82e-04 | 2 | 270 | 2 | GO:0001639 | |
| GeneOntologyMolecularFunction | histone H2B kinase activity | 1.82e-04 | 2 | 270 | 2 | GO:0140998 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 4.49e-04 | 27 | 270 | 4 | GO:0004709 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.49e-04 | 27 | 270 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | procollagen glucosyltransferase activity | 5.42e-04 | 3 | 270 | 2 | GO:0033823 | |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 5.42e-04 | 3 | 270 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 5.42e-04 | 3 | 270 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | procollagen-lysine 5-dioxygenase activity | 5.42e-04 | 3 | 270 | 2 | GO:0008475 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 5.42e-04 | 3 | 270 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | integrin binding | 6.47e-04 | 175 | 270 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 6.58e-04 | 78 | 270 | 6 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 7.52e-04 | 80 | 270 | 6 | GO:0008186 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 9.86e-04 | 15 | 270 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.07e-03 | 4 | 270 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 1.07e-03 | 4 | 270 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.07e-03 | 4 | 270 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | ubiquitin activating enzyme activity | 1.07e-03 | 4 | 270 | 2 | GO:0004839 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.07e-03 | 4 | 270 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | peptidyl-lysine 5-dioxygenase activity | 1.07e-03 | 4 | 270 | 2 | GO:0070815 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 1.07e-03 | 4 | 270 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 1.07e-03 | 4 | 270 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activator activity | 1.37e-03 | 36 | 270 | 4 | GO:0030296 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ADAM20 SRC EVPL ITGA2B EPS15L1 PKM GPNMB HSP90AB1 ANK3 ICAM2 ADGRL1 GLOD4 S1PR3 TGFBI EGFR PKP3 CD40LG ENO1 | 1.40e-03 | 599 | 270 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | helicase activity | 1.42e-03 | 158 | 270 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | kinase binding | PRPSAP1 TRAF6 ACACA SRC CLASP2 RYR2 KSR1 BRAF SNAP91 NBEAL2 FGR HSF1 HSP90AB1 ADCY4 KSR2 LCK GRM5 CASK EGFR MTOR PRKAA1 APPL1 PRKCD MAPK6 ATP1A4 | 1.55e-03 | 969 | 270 | 25 | GO:0019900 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.72e-03 | 18 | 270 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.73e-03 | 163 | 270 | 8 | GO:0031072 | |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 1.77e-03 | 5 | 270 | 2 | GO:0004749 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 2.02e-03 | 19 | 270 | 3 | GO:0031434 | |
| GeneOntologyMolecularFunction | adenosine 3',5'-bisphosphate transmembrane transporter activity | 2.64e-03 | 6 | 270 | 2 | GO:0071077 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 2.64e-03 | 6 | 270 | 2 | GO:0016778 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 3.11e-03 | 22 | 270 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 3.11e-03 | 22 | 270 | 3 | GO:0046527 | |
| GeneOntologyBiologicalProcess | response to caffeine | 2.05e-07 | 21 | 267 | 6 | GO:0031000 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 3.29e-06 | 9 | 267 | 4 | GO:0007196 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | EPHB4 SRC GPNMB FGR ALK DDR1 LCK EGFR MTOR MAP3K21 HCK EPHA7 EPHB1 | 9.23e-06 | 228 | 267 | 13 | GO:0046777 |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 1.01e-05 | 39 | 267 | 6 | GO:0038094 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | SENP3 SRC JAK3 NAA25 GRK2 BRAF SPHK1 DHPS FNIP1 FGR PRMT7 HSF1 PLOD1 ALK DDR1 PLOD3 CAMK1D HBEGF LCK GRM5 EGFR MTOR PRKAA1 PRKAA2 PRKCD PRKCI HCK HDAC2 EPHA7 RASD2 | 1.07e-05 | 976 | 267 | 30 | GO:0018193 |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 1.50e-05 | 25 | 267 | 5 | GO:0038096 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 1.50e-05 | 25 | 267 | 5 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 1.51e-05 | 62 | 267 | 7 | GO:0038093 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | ADGRB2 GRK2 GPBAR1 ADCY4 ADGRG3 FPR1 ADGRL1 GRM1 GPR88 GRM5 GRM7 GRM8 S1PR3 GABBR1 | 2.35e-05 | 286 | 267 | 14 | GO:0007188 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | SRC JAK3 FGR HSF1 ALK DDR1 HBEGF LCK GRM5 EGFR MTOR PRKCD HCK HDAC2 EPHA7 | 2.57e-05 | 327 | 267 | 15 | GO:0018108 |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 2.64e-05 | 182 | 267 | 11 | GO:0006195 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | SRC JAK3 FGR HSF1 ALK DDR1 HBEGF LCK GRM5 EGFR MTOR PRKCD HCK HDAC2 EPHA7 | 2.76e-05 | 329 | 267 | 15 | GO:0018212 |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 3.57e-05 | 188 | 267 | 11 | GO:0072523 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | PRPSAP1 PRPSAP2 NMNAT2 ACACA SRC NCF2 GNMT PKM DLST ABCD1 GPD2 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 4.40e-05 | 652 | 267 | 22 | GO:0072521 |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 4.42e-05 | 16 | 267 | 4 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of sphingolipid biosynthetic process | 4.42e-05 | 16 | 267 | 4 | GO:0090153 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 5.21e-05 | 196 | 267 | 11 | GO:0016052 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | PRPSAP1 PRPSAP2 ABCA2 ACACA SRC NDST4 DHDDS GNMT XYLT2 JAK3 GANAB PKM DLST XYLB ABCD1 PLOD1 GPD2 ADCY4 PLOD3 HBEGF NDST2 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 XXYLT1 NT5C2 PRKCD ENO1 | 5.52e-05 | 1226 | 267 | 33 | GO:1901135 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | PRPSAP1 PRPSAP2 NMNAT2 ACACA SRC NCF2 PKM DLST ABCD1 GPD2 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 6.09e-05 | 619 | 267 | 21 | GO:0006163 |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 6.84e-05 | 202 | 267 | 11 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 6.84e-05 | 202 | 267 | 11 | GO:0019362 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid translocation | 7.22e-05 | 7 | 267 | 3 | GO:0061091 | |
| GeneOntologyBiologicalProcess | negative regulation of sphingolipid biosynthetic process | 7.22e-05 | 7 | 267 | 3 | GO:0090155 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 7.34e-05 | 169 | 267 | 10 | GO:0009154 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 8.27e-05 | 35 | 267 | 5 | GO:0002431 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 8.90e-05 | 208 | 267 | 11 | GO:0009166 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 9.69e-05 | 210 | 267 | 11 | GO:0072524 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 1.13e-04 | 178 | 267 | 10 | GO:0009261 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB4 EPHA6 SRC FSTL4 CLASP2 JAK3 BRAF FGR ALK DOCK3 DDR1 HBEGF HIP1R SESN3 IDE LCK EGFR PRKAA1 APPL1 PRKCD HCK EPHA7 EPHB1 | 1.17e-04 | 747 | 267 | 23 | GO:0007169 |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 1.24e-04 | 216 | 267 | 11 | GO:1901292 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.27e-04 | 86 | 267 | 7 | GO:0007193 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 1.61e-04 | 119 | 267 | 8 | GO:0019364 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 1.67e-04 | 22 | 267 | 4 | GO:0038083 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PRPSAP1 PRPSAP2 NMNAT2 ABCA2 ACACA SRC DHDDS NCF2 EFR3A GRK3 TTC7B PKM DLST PLCD1 XYLB ABCD1 GPD2 ADCY4 INPP5E OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 PRKCD ENO1 | 1.88e-04 | 1142 | 267 | 30 | GO:0019637 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | CCR9 ADGRB2 RYR1 RYR2 RYR3 SPHK1 LMCD1 KSR2 GRM1 GRM5 MTOR PRKAA1 | 1.93e-04 | 266 | 267 | 12 | GO:0019722 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | MYO5B PSMC5 CLSTN2 GIT2 EFR3A DLGAP3 GRK2 BRAF SNAP91 SPHK1 SYN2 SLITRK3 GRM1 GRM5 GRM7 GRM8 CASK EGFR GUCY1B1 MTOR SLC6A5 HTR3B GABBR1 EPHA7 EPHB1 RASD2 | 2.01e-04 | 931 | 267 | 26 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | MYO5B PSMC5 CLSTN2 GIT2 EFR3A DLGAP3 GRK2 BRAF SNAP91 SPHK1 SYN2 SLITRK3 GRM1 GRM5 GRM7 GRM8 CASK EGFR GUCY1B1 MTOR SLC6A5 HTR3B GABBR1 EPHA7 EPHB1 RASD2 | 2.01e-04 | 931 | 267 | 26 | GO:0007268 |
| GeneOntologyBiologicalProcess | NADH metabolic process | 2.01e-04 | 42 | 267 | 5 | GO:0006734 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 2.03e-04 | 123 | 267 | 8 | GO:0072526 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | EPHB4 TRAF6 SRC MAP3K4 GRK3 BRAF SPHK1 FNIP1 PLCD1 GPNMB HSF1 ALK HSP90AB1 DDR1 HBEGF LCK GRM5 EGFR MTOR PRKAA1 PRKAA2 PRKCD ENO1 HDAC2 EPHA7 | 2.03e-04 | 879 | 267 | 25 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | EPHB4 TRAF6 SRC MAP3K4 GRK3 BRAF SPHK1 FNIP1 PLCD1 GPNMB HSF1 ALK HSP90AB1 DDR1 HBEGF LCK GRM5 EGFR MTOR PRKAA1 PRKAA2 PRKCD ENO1 HDAC2 EPHA7 | 2.03e-04 | 879 | 267 | 25 | GO:0045937 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | MYO5B PSMC5 CLSTN2 GIT2 EFR3A DLGAP3 GRK2 BRAF SNAP91 SPHK1 SYN2 SLITRK3 GRM1 GRM5 GRM7 GRM8 CASK EGFR GUCY1B1 MTOR SLC6A5 HTR3B GABBR1 EPHA7 EPHB1 RASD2 | 2.30e-04 | 939 | 267 | 26 | GO:0099537 |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | PRPSAP1 PRPSAP2 NMNAT2 ACACA SRC NCF2 PKM DLST ABCD1 GPD2 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 2.42e-04 | 684 | 267 | 21 | GO:0009117 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | PRPSAP1 PRPSAP2 ACACA SRC PKM DLST ABCD1 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 2.54e-04 | 540 | 267 | 18 | GO:0019693 |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.57e-04 | 161 | 267 | 9 | GO:0051592 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | PRPSAP1 PRPSAP2 NMNAT2 ACACA SRC NCF2 PKM DLST ABCD1 GPD2 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 2.77e-04 | 691 | 267 | 21 | GO:0006753 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid metabolic process | 2.80e-04 | 25 | 267 | 4 | GO:1905038 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | SRC NCF2 PKM ABCD1 OGDH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 PRKCD ENO1 | 3.18e-04 | 281 | 267 | 12 | GO:0046434 |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 3.28e-04 | 11 | 267 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.28e-04 | 11 | 267 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | establishment of sister chromatid cohesion | 3.28e-04 | 11 | 267 | 3 | GO:0034085 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 3.28e-04 | 132 | 267 | 8 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 3.28e-04 | 132 | 267 | 8 | GO:0009179 | |
| GeneOntologyBiologicalProcess | positive regulation of ATP metabolic process | 3.80e-04 | 48 | 267 | 5 | GO:1903580 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | MYO5B ADGRB2 CLSTN2 WLS BRAF SNAP91 ADGRL1 SLITRK3 GRM5 CASK EGFR MTOR PRKCI HDAC2 EPHB1 | 3.86e-04 | 418 | 267 | 15 | GO:0051962 |
| GeneOntologyBiologicalProcess | synaptic signaling | MYO5B PSMC5 CLSTN2 GIT2 EFR3A DLGAP3 GRK2 BRAF SNAP91 SPHK1 SYN2 SLITRK3 GRM1 GRM5 GRM7 GRM8 CASK EGFR GUCY1B1 MTOR SLC6A5 HTR3B GABBR1 EPHA7 EPHB1 RASD2 | 4.15e-04 | 976 | 267 | 26 | GO:0099536 |
| GeneOntologyBiologicalProcess | NAD metabolic process | 4.24e-04 | 75 | 267 | 6 | GO:0019674 | |
| GeneOntologyBiologicalProcess | regulation of stress granule assembly | 4.33e-04 | 12 | 267 | 3 | GO:0062028 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-lysine acetylation | 4.33e-04 | 12 | 267 | 3 | GO:2000756 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | PRPSAP1 PRPSAP2 NMNAT2 ACACA SRC NCF2 GNMT PKM DLST ABCD1 GPD2 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 4.39e-04 | 767 | 267 | 22 | GO:0055086 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled glutamate receptor signaling pathway | 4.97e-04 | 3 | 267 | 2 | GO:0007206 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 4.97e-04 | 3 | 267 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet-derived growth factor receptor-beta signaling pathway | 4.97e-04 | 3 | 267 | 2 | GO:2000588 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide catabolic process | 5.05e-04 | 29 | 267 | 4 | GO:0033123 | |
| GeneOntologyBiologicalProcess | positive regulation of glycolytic process | 5.05e-04 | 29 | 267 | 4 | GO:0045821 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide catabolic process | 5.05e-04 | 29 | 267 | 4 | GO:0030813 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 5.06e-04 | 51 | 267 | 5 | GO:0031295 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 5.60e-04 | 143 | 267 | 8 | GO:0009185 | |
| GeneOntologyBiologicalProcess | glycolytic process | 5.77e-04 | 110 | 267 | 7 | GO:0006096 | |
| GeneOntologyBiologicalProcess | fatty acid beta-oxidation | 6.00e-04 | 80 | 267 | 6 | GO:0006635 | |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 6.05e-04 | 53 | 267 | 5 | GO:0031294 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | MYO5B DOCK11 SRC ADGRB2 PSMC5 CLASP2 CLSTN2 BRAF SNAP91 FNIP1 HSF1 HIP1R ADGRL1 SLITRK3 MORC2 MTOR HCK EPHB1 | 6.16e-04 | 582 | 267 | 18 | GO:0044089 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 6.60e-04 | 54 | 267 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | cellular response to hydrogen peroxide | 6.84e-04 | 82 | 267 | 6 | GO:0070301 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 7.02e-04 | 14 | 267 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | regulation of ceramide biosynthetic process | 7.02e-04 | 14 | 267 | 3 | GO:2000303 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 7.14e-04 | 114 | 267 | 7 | GO:0046032 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide metabolic process | 7.18e-04 | 55 | 267 | 5 | GO:0045981 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide metabolic process | 7.18e-04 | 55 | 267 | 5 | GO:1900544 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 7.35e-04 | 149 | 267 | 8 | GO:0009132 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | SRC NDST4 TKTL1 GNMT GANAB BRAF AGL PKM PLCD1 XYLB GPD2 NDST2 OGDH CASD1 MTOR GYS2 PRKAA1 PRKAA2 ENO1 | 7.99e-04 | 646 | 267 | 19 | GO:0005975 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | SRC RYR1 RYR2 RYR3 JAK3 GRK2 PKM HSF1 ALK SESN3 IDE GRM5 IFIT1 GUCY1B1 MTOR PRKAA1 APPL1 PRKCD PRKCI HTR3B HDAC2 | 8.31e-04 | 752 | 267 | 21 | GO:1901699 |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 8.33e-04 | 117 | 267 | 7 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 8.33e-04 | 117 | 267 | 7 | GO:0009181 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHA6 MYO5B SRC GAS2 FSTL4 CLASP2 WLS BRAF SNAP91 NBEAL2 PDZD8 FGR DDR1 PLOD3 ANK3 PLEKHG4 SLITRK3 PREX2 CASK IGF2BP1 CELSR3 EGFR SMARCA4 ARPIN HCK MYO16 EPB41L2 EPHA7 EPHB1 | 8.53e-04 | 1194 | 267 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor-beta signaling pathway | 8.70e-04 | 15 | 267 | 3 | GO:0035791 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 9.38e-04 | 34 | 267 | 4 | GO:0090311 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 9.66e-04 | 120 | 267 | 7 | GO:0046031 | |
| GeneOntologyBiologicalProcess | negative regulation of lysosome organization | 9.85e-04 | 4 | 267 | 2 | GO:1905672 | |
| GeneOntologyBiologicalProcess | protein localization to lipid droplet | 9.85e-04 | 4 | 267 | 2 | GO:1990044 | |
| GeneOntologyBiologicalProcess | positive regulation of clathrin coat assembly | 9.85e-04 | 4 | 267 | 2 | GO:1905445 | |
| GeneOntologyBiologicalProcess | positive regulation of cholangiocyte proliferation | 9.85e-04 | 4 | 267 | 2 | GO:1904056 | |
| GeneOntologyBiologicalProcess | cellular response to bile acid | 9.85e-04 | 4 | 267 | 2 | GO:1903413 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 1.01e-03 | 121 | 267 | 7 | GO:0009191 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin E stimulus | 1.06e-03 | 16 | 267 | 3 | GO:0071380 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid transport | 1.06e-03 | 16 | 267 | 3 | GO:2001138 | |
| GeneOntologyBiologicalProcess | fatty acid oxidation | 1.06e-03 | 122 | 267 | 7 | GO:0019395 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.07e-03 | 60 | 267 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | MYO5B PSMC5 CLSTN2 GIT2 DLGAP3 GRK2 BRAF SPHK1 GRM1 GRM5 GRM7 GRM8 CASK EGFR GUCY1B1 MTOR GABBR1 EPHA7 EPHB1 | 1.08e-03 | 663 | 267 | 19 | GO:0050804 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | ACACA SRC PKM DLST ABCD1 ADCY4 OGDH CASK GUCY1B1 EHHADH MTOR PDE8B PRKAA1 PRKAA2 NT5C2 ENO1 | 1.10e-03 | 512 | 267 | 16 | GO:0009150 |
| GeneOntologyCellularComponent | glutamatergic synapse | TRAF6 MYO5B SRC ADGRB2 CLASP2 CLSTN2 EFR3A DLGAP3 GRK2 GRK3 BRAF NAE1 SYN2 DOCK1 HIP1R ADGRL1 LCK GRM1 GRM5 GRM7 GRM8 CELSR3 GUCY1B1 MTOR APPL1 PRKCI GABBR1 EPHA7 EPHB1 | 9.03e-07 | 817 | 270 | 29 | GO:0098978 |
| GeneOntologyCellularComponent | cell body | PDE1C PDE1B MAOB CCT3 MYO5B SRC DLGAP3 BRAF SNAP91 ALK HSP90AB1 HIP1R GRM1 GRM7 GRM8 CASK IGF2BP1 MTOR ASL IGHMBP2 PRKAA1 PRKAA2 CD40LG HTR3B GABBR1 EPHA7 | 1.89e-04 | 929 | 270 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.91e-04 | 155 | 270 | 9 | GO:0098685 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PDE1C EPHA6 PDE1B MAOB MYO5B SRC CLSTN2 WLS DLGAP3 GRK2 GRK3 SNAP91 HSP90AB1 ADCY4 ANK3 HIP1R GRM1 GRM5 GRM7 GRM8 CASK IGF2BP1 MTOR ASL IGHMBP2 PRKAA1 PRKAA2 HTR3B GABBR1 EPHA7 EPHB1 | 2.84e-04 | 1228 | 270 | 31 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | EPHA6 MAOB MYO5B SRC CLSTN2 WLS DLGAP3 GRK2 GRK3 HSP90AB1 ADCY4 ANK3 HIP1R GRM1 GRM5 GRM7 CASK IGF2BP1 MTOR PRKAA1 PRKAA2 GABBR1 EPHA7 EPHB1 | 3.38e-04 | 858 | 270 | 24 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHA6 MAOB MYO5B SRC CLSTN2 WLS DLGAP3 GRK2 GRK3 HSP90AB1 ADCY4 ANK3 HIP1R GRM1 GRM5 GRM7 CASK IGF2BP1 MTOR PRKAA1 PRKAA2 GABBR1 EPHA7 EPHB1 | 3.49e-04 | 860 | 270 | 24 | GO:0097447 |
| GeneOntologyCellularComponent | leading edge membrane | 4.22e-04 | 210 | 270 | 10 | GO:0031256 | |
| GeneOntologyCellularComponent | ruffle membrane | 5.10e-04 | 108 | 270 | 7 | GO:0032587 | |
| GeneOntologyCellularComponent | synaptic membrane | SRC CLSTN2 SNAP91 ANK3 HIP1R ADGRL1 SLITRK3 GRM1 GRM5 GRM7 GRM8 CASK CELSR3 SLC6A5 HTR3B ENO1 GABBR1 EPHA7 | 6.14e-04 | 583 | 270 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | BRPF3 CCT3 MARCHF6 PSMC5 UBE4A NAA25 MORF4L1 HSF1 RIC1 HSP90AB1 DOCK1 PRAMEF22 POLG SESN3 IDE CCDC61 IGF2BP1 POLR3B CBX6 MTOR CIAO3 PRKAA1 PRKAA2 FBXO21 KAT14 | 8.62e-04 | 972 | 270 | 25 | GO:0140535 |
| Domain | Kinase-like_dom | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC WDR81 MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 ACAD11 BRAF FGR ALK DDR1 CAMK1D ADCK5 KSR2 LCK CASK EGFR MTOR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 1.32e-14 | 542 | 266 | 36 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 BRAF FGR ALK DDR1 CAMK1D ADCK5 KSR2 LCK CASK EGFR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 1.48e-13 | 493 | 266 | 33 | PS50011 |
| Domain | Prot_kinase_dom | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 KSR1 NEK1 GRK2 GRK3 BRAF FGR ALK DDR1 CAMK1D KSR2 LCK CASK EGFR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 6.56e-13 | 489 | 266 | 32 | IPR000719 |
| Domain | PROTEIN_KINASE_ATP | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 NEK1 GRK2 GRK3 BRAF FGR ALK DDR1 CAMK1D ADCK5 LCK CASK EGFR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 6.77e-13 | 459 | 266 | 31 | PS00107 |
| Domain | Protein_kinase_ATP_BS | EPHB4 CDK17 EPHA6 PSKH1 SPEG SRC MAP3K4 JAK3 NEK1 GRK2 GRK3 BRAF FGR ALK CAMK1D LCK EGFR PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 HCK EPHA7 EPHB1 | 6.66e-12 | 379 | 266 | 27 | IPR017441 |
| Domain | Pkinase_Tyr | EPHB4 EPHA6 SRC JAK3 KSR1 BRAF FGR ALK DDR1 KSR2 LCK EGFR MAP3K21 HCK EPHA7 EPHB1 | 4.62e-11 | 129 | 266 | 16 | PF07714 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | EPHB4 EPHA6 SRC JAK3 KSR1 BRAF FGR ALK DDR1 KSR2 LCK EGFR MAP3K21 HCK EPHA7 EPHB1 | 1.30e-10 | 138 | 266 | 16 | IPR001245 |
| Domain | Tyr_kinase_cat_dom | EPHB4 EPHA6 SRC JAK3 FGR ALK DDR1 LCK EGFR MAP3K21 HCK EPHA7 EPHB1 | 3.44e-10 | 88 | 266 | 13 | IPR020635 |
| Domain | TyrKc | EPHB4 EPHA6 SRC JAK3 FGR ALK DDR1 LCK EGFR MAP3K21 HCK EPHA7 EPHB1 | 3.44e-10 | 88 | 266 | 13 | SM00219 |
| Domain | PROTEIN_KINASE_TYR | 1.32e-08 | 97 | 266 | 12 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.32e-08 | 97 | 266 | 12 | IPR008266 | |
| Domain | ARM-type_fold | DOCK11 CLASP2 TRIP12 NCAPG2 RYR3 EFR3A NBEAL2 ANKAR NIPBL DOCK1 DOCK3 INTS7 DOCK8 IPO9 MTOR PKP3 IQCB1 LTN1 DAAM2 STAG3 | 9.37e-08 | 339 | 266 | 20 | IPR016024 |
| Domain | Ser/Thr_kinase_AS | CDK17 PSKH1 SPEG MAP3K4 KSR1 NEK1 GRK2 GRK3 BRAF CAMK1D KSR2 CASK PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 NEK11 | 2.16e-07 | 357 | 266 | 20 | IPR008271 |
| Domain | S_TKc | CDK17 PSKH1 SPEG MAP3K4 KSR1 NEK1 GRK2 GRK3 BRAF CAMK1D KSR2 CASK PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 NEK11 | 2.36e-07 | 359 | 266 | 20 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CDK17 PSKH1 SPEG MAP3K4 KSR1 NEK1 GRK2 GRK3 BRAF CAMK1D KSR2 CASK PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 PSKH2 NEK11 | 2.70e-07 | 362 | 266 | 20 | PS00108 |
| Domain | ARM-like | CLASP2 TRIP12 NCAPG2 EFR3A NBEAL2 ANKAR NIPBL INTS7 DOCK8 IPO9 MTOR PKP3 IQCB1 LTN1 DAAM2 STAG3 | 1.76e-06 | 270 | 266 | 16 | IPR011989 |
| Domain | GPCR_3_mtglu_rcpt | 2.69e-06 | 8 | 266 | 4 | IPR000162 | |
| Domain | RyR | 2.86e-06 | 3 | 266 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 2.86e-06 | 3 | 266 | 3 | PF06459 | |
| Domain | Ryan_recept | 2.86e-06 | 3 | 266 | 3 | IPR013333 | |
| Domain | Ryanodine_rcpt | 2.86e-06 | 3 | 266 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.86e-06 | 3 | 266 | 3 | IPR009460 | |
| Domain | Pkinase | CDK17 PSKH1 SPEG MAP3K4 NEK1 GRK2 GRK3 BRAF CAMK1D KSR2 CASK PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 PSKH2 NEK11 | 9.65e-06 | 381 | 266 | 18 | PF00069 |
| Domain | 7tm_3 | 1.22e-05 | 22 | 266 | 5 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.22e-05 | 22 | 266 | 5 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.22e-05 | 22 | 266 | 5 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.22e-05 | 22 | 266 | 5 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.22e-05 | 22 | 266 | 5 | PS50259 | |
| Domain | GPCR_3_C | 1.22e-05 | 22 | 266 | 5 | IPR017978 | |
| Domain | DOCK | 1.23e-05 | 11 | 266 | 4 | IPR026791 | |
| Domain | DOCK_C | 1.23e-05 | 11 | 266 | 4 | IPR010703 | |
| Domain | DOCK-C2 | 1.23e-05 | 11 | 266 | 4 | PF14429 | |
| Domain | DHR-1_domain | 1.23e-05 | 11 | 266 | 4 | IPR027007 | |
| Domain | DHR_2 | 1.23e-05 | 11 | 266 | 4 | PS51651 | |
| Domain | DHR_1 | 1.23e-05 | 11 | 266 | 4 | PS51650 | |
| Domain | DHR-2 | 1.23e-05 | 11 | 266 | 4 | PF06920 | |
| Domain | DHR-2 | 1.23e-05 | 11 | 266 | 4 | IPR027357 | |
| Domain | GPCR_3_9-Cys_dom | 2.60e-05 | 13 | 266 | 4 | IPR011500 | |
| Domain | NCD3G | 2.60e-05 | 13 | 266 | 4 | PF07562 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 3.60e-05 | 14 | 266 | 4 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 3.60e-05 | 14 | 266 | 4 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 3.60e-05 | 14 | 266 | 4 | IPR001426 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 3.60e-05 | 14 | 266 | 4 | IPR001090 | |
| Domain | Eph_TM | 3.60e-05 | 14 | 266 | 4 | IPR027936 | |
| Domain | EphA2_TM | 3.60e-05 | 14 | 266 | 4 | PF14575 | |
| Domain | EPH_lbd | 3.60e-05 | 14 | 266 | 4 | SM00615 | |
| Domain | Ephrin_lbd | 3.60e-05 | 14 | 266 | 4 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 3.60e-05 | 14 | 266 | 4 | IPR016257 | |
| Domain | EPH_LBD | 3.60e-05 | 14 | 266 | 4 | PS51550 | |
| Domain | GPCR_3_CS | 3.60e-05 | 14 | 266 | 4 | IPR017979 | |
| Domain | AAA+_ATPase | ABCA2 PSMC5 BCS1L ABCB4 MDN1 ABCD1 DNAH8 DNAH10 ABCB5 IGHMBP2 | 4.17e-05 | 144 | 266 | 10 | IPR003593 |
| Domain | AAA | ABCA2 PSMC5 BCS1L ABCB4 MDN1 ABCD1 DNAH8 DNAH10 ABCB5 IGHMBP2 | 4.17e-05 | 144 | 266 | 10 | SM00382 |
| Domain | Ryanodine_recept-rel | 5.53e-05 | 6 | 266 | 3 | IPR015925 | |
| Domain | - | 5.53e-05 | 6 | 266 | 3 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 5.53e-05 | 6 | 266 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.53e-05 | 6 | 266 | 3 | PF08709 | |
| Domain | RIH_assoc | 5.53e-05 | 6 | 266 | 3 | PF08454 | |
| Domain | RIH_dom | 5.53e-05 | 6 | 266 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.53e-05 | 6 | 266 | 3 | IPR014821 | |
| Domain | RYDR_ITPR | 5.53e-05 | 6 | 266 | 3 | PF01365 | |
| Domain | - | CLASP2 TRIP12 NCAPG2 EFR3A ANKAR NIPBL INTS7 IPO9 MTOR PKP3 DAAM2 STAG3 | 8.53e-05 | 222 | 266 | 12 | 1.25.10.10 |
| Domain | C1_1 | 1.56e-04 | 57 | 266 | 6 | PF00130 | |
| Domain | ANF_lig-bd_rcpt | 1.69e-04 | 37 | 266 | 5 | IPR001828 | |
| Domain | ANF_receptor | 1.69e-04 | 37 | 266 | 5 | PF01094 | |
| Domain | GPCR_3 | 1.99e-04 | 21 | 266 | 4 | IPR000337 | |
| Domain | KSR1-SAM | 2.02e-04 | 2 | 266 | 2 | PF13543 | |
| Domain | Metabotropic_Glu_rcpt_Homer-bd | 2.02e-04 | 2 | 266 | 2 | IPR019588 | |
| Domain | AdenylateSensor | 2.02e-04 | 2 | 266 | 2 | PF16579 | |
| Domain | GluR_Homer-bdg | 2.02e-04 | 2 | 266 | 2 | PF10606 | |
| Domain | Vert_HSTF_C | 2.02e-04 | 2 | 266 | 2 | IPR010542 | |
| Domain | GPCR_3_mtglu_rcpt_1 | 2.02e-04 | 2 | 266 | 2 | IPR001256 | |
| Domain | Vert_HS_TF | 2.02e-04 | 2 | 266 | 2 | PF06546 | |
| Domain | GluR_Homer-bdg | 2.02e-04 | 2 | 266 | 2 | SM01229 | |
| Domain | AMPK_C | 2.02e-04 | 2 | 266 | 2 | IPR032270 | |
| Domain | GPCR_3_mtglu_rcpt_5 | 2.02e-04 | 2 | 266 | 2 | IPR000202 | |
| Domain | KSR_SAM-like_dom | 2.02e-04 | 2 | 266 | 2 | IPR025561 | |
| Domain | Peripla_BP_I | 2.19e-04 | 39 | 266 | 5 | IPR028082 | |
| Domain | ZF_DAG_PE_2 | 2.96e-04 | 64 | 266 | 6 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 2.96e-04 | 64 | 266 | 6 | PS00479 | |
| Domain | MIR | 3.18e-04 | 10 | 266 | 3 | PF02815 | |
| Domain | MIR_motif | 3.18e-04 | 10 | 266 | 3 | IPR016093 | |
| Domain | MIR | 3.18e-04 | 10 | 266 | 3 | PS50919 | |
| Domain | MIR | 3.18e-04 | 10 | 266 | 3 | SM00472 | |
| Domain | C1 | 3.22e-04 | 65 | 266 | 6 | SM00109 | |
| Domain | PE/DAG-bd | 3.50e-04 | 66 | 266 | 6 | IPR002219 | |
| Domain | Ephrin_rec_like | 4.02e-04 | 25 | 266 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 4.02e-04 | 25 | 266 | 4 | IPR011641 | |
| Domain | GAIN_dom_N | 4.33e-04 | 11 | 266 | 3 | IPR032471 | |
| Domain | GAIN | 4.33e-04 | 11 | 266 | 3 | PF16489 | |
| Domain | P-loop_NTPase | ABCA2 MYO5B BMS1 NDST4 PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DNAH10 DDX60 ABCB5 NDST2 GFM2 CASK IGHMBP2 IQCB1 SMARCA4 DDX39A MYO16 RASD2 | 4.88e-04 | 848 | 266 | 25 | IPR027417 |
| Domain | Procol_lys_dOase | 6.01e-04 | 3 | 266 | 2 | IPR001006 | |
| Domain | PDEase_N | 6.01e-04 | 3 | 266 | 2 | IPR013706 | |
| Domain | LYS_HYDROXYLASE | 6.01e-04 | 3 | 266 | 2 | PS01325 | |
| Domain | PDEase_I_N | 6.01e-04 | 3 | 266 | 2 | PF08499 | |
| Domain | Pur_nucleotidase | 6.01e-04 | 3 | 266 | 2 | IPR016695 | |
| Domain | ATPase_dyneun-rel_AAA | 9.26e-04 | 14 | 266 | 3 | IPR011704 | |
| Domain | AAA_5 | 9.26e-04 | 14 | 266 | 3 | PF07728 | |
| Domain | DEXDc | 9.52e-04 | 109 | 266 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.00e-03 | 110 | 266 | 7 | IPR014001 | |
| Domain | - | ABCA2 BMS1 NDST4 PSMC5 CHD3 BCS1L ABCB4 MDN1 DDX23 DDX60L ABCD1 DNAH8 DNAH10 DDX60 ABCB5 NDST2 GFM2 CASK IGHMBP2 SMARCA4 DDX39A RASD2 | 1.06e-03 | 746 | 266 | 22 | 3.40.50.300 |
| Pathway | PID_EPHRINB_REV_PATHWAY | 2.80e-07 | 30 | 217 | 7 | M257 | |
| Pathway | PID_TXA2PATHWAY | 2.09e-06 | 56 | 217 | 8 | M99 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.19e-06 | 15 | 217 | 5 | MM15845 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.19e-06 | 15 | 217 | 5 | M39442 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 8.05e-06 | 32 | 217 | 6 | M275 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.16e-05 | 34 | 217 | 6 | M177 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | PDE1C TRAF6 PDE1B SRC PSMC5 CHD3 GRK2 ADCY4 HBEGF LCK PREX2 EGFR CBX6 MTOR PRKCD HDAC2 | 2.79e-05 | 313 | 217 | 16 | M27867 |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | PDE1C TRAF6 PDE1B SRC PSMC5 CHD3 GRK2 ADCY4 HBEGF LCK PREX2 EGFR MTOR PRKCD | 3.63e-05 | 252 | 217 | 14 | MM15585 |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 4.17e-05 | 26 | 217 | 5 | MM14495 | |
| Pathway | REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION | 6.95e-05 | 6 | 217 | 3 | M27754 | |
| Pathway | REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION | 6.95e-05 | 6 | 217 | 3 | MM15500 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 7.74e-05 | 144 | 217 | 10 | M39691 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 8.59e-05 | 30 | 217 | 5 | M76 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 9.81e-05 | 178 | 217 | 11 | M2890 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.18e-04 | 32 | 217 | 5 | MM15326 | |
| Pathway | PID_PTP1B_PATHWAY | 1.40e-04 | 52 | 217 | 6 | M50 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.60e-04 | 34 | 217 | 5 | MM15025 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.76e-04 | 102 | 217 | 8 | MM15830 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.76e-04 | 102 | 217 | 8 | M39577 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 2.41e-04 | 37 | 217 | 5 | MM15067 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.41e-04 | 37 | 217 | 5 | M749 | |
| Pathway | WP_GPCRS_NONODORANT | CCR9 ADGRB2 GPBAR1 LPAR5 FPR1 ADGRL1 GRM1 GRM5 GRM7 GRM8 S1PR3 CELSR3 GABBR1 | 2.47e-04 | 266 | 217 | 13 | MM15843 |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.10e-04 | 39 | 217 | 5 | MM15272 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.10e-04 | 39 | 217 | 5 | MM14496 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.10e-04 | 39 | 217 | 5 | M793 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.50e-04 | 40 | 217 | 5 | M27557 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.94e-04 | 41 | 217 | 5 | M512 | |
| Pathway | BIOCARTA_LEPTIN_PATHWAY | 5.42e-04 | 11 | 217 | 3 | M18053 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.42e-04 | 11 | 217 | 3 | M47958 | |
| Pathway | WP_GLYCOLYSIS_IN_SENESCENCE | 5.42e-04 | 11 | 217 | 3 | M40053 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | PDE1C PDE1B CCR9 SRC GRK2 ADCY4 LPAR5 FPR1 GRM7 GRM8 S1PR3 PRKCD GABBR1 | 5.47e-04 | 289 | 217 | 13 | MM15057 |
| Pathway | KEGG_LYSINE_DEGRADATION | 5.50e-04 | 44 | 217 | 5 | M13720 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 5.67e-04 | 67 | 217 | 6 | MM15327 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ACACA MAOB GNMT DLGAP3 GRM1 GRM5 GRM7 GRM8 EGFR MTOR PRKAA1 PRKAA2 PRKCD HTR3B GABBR1 | 5.70e-04 | 367 | 217 | 15 | M48346 |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 6.11e-04 | 45 | 217 | 5 | M27623 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 6.64e-04 | 69 | 217 | 6 | M237 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 7.26e-04 | 27 | 217 | 4 | M33 | |
| Pubmed | EPHB4 SRC MAP3K4 JAK3 KSR1 GRK2 SPHK1 PLOD1 ALK HSP90AB1 DDR1 CAMK1D LCK CASK IGF2BP1 EGFR PRKAA1 PRKCD HCK | 8.63e-13 | 276 | 272 | 19 | 28319085 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | PSKH1 KLHL32 KSR1 AREL1 BRAF FGR ALK HSP90AB1 KLHL6 DDR1 POGK KSR2 LCK EGFR PRKAA1 PRKAA2 PRKCI PSKH2 HCK NEK11 EPHB1 | 2.42e-12 | 372 | 272 | 21 | 22939624 |
| Pubmed | 2.43e-12 | 83 | 272 | 12 | 11114734 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 ABCA2 ACACA MORN1 SPEG ADGRB2 CLASP2 ARHGEF11 RYR1 ACOX3 JAK3 EPS15L1 MDN1 SPHK1 NBEAL2 PDZD8 ABCD1 RIC1 DOCK3 PLOD3 LPAR5 INPP5E POLG KSR2 HIP1R TRMT1 ADGRL1 CELSR3 MTOR XXYLT1 PCNX1 DISP2 ZNF324B TOP3A RASD2 | 2.61e-12 | 1105 | 272 | 35 | 35748872 |
| Pubmed | PDE1B CCT3 DOCK11 SENP3 SRC ADGRB2 WDR81 CLASP2 GIT2 ARHGEF11 DLGAP3 EPS15L1 UBA1 MDN1 SNAP91 MORF4L1 NIPBL HSP90AB1 ANK3 KSR2 GRM1 GRM5 CASK MTOR NT5C2 SMARCA4 APPL1 PRKCI ENO1 EPB41L2 HDAC2 | 3.43e-11 | 963 | 272 | 31 | 28671696 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP1 PRPSAP2 ACACA CCT3 PSMC5 TRIP12 NCAPG2 MAP3K4 AGL PKM DNAH8 NIPBL POGK TRMT1 MORC2 IGF2BP1 POLR3B MTOR MRPS26 LTN1 SMARCA4 PRKCI DDX39A EPB41L2 | 2.11e-09 | 704 | 272 | 24 | 29955894 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NMNAT2 DYM ACACA EPHA6 MORN1 SRC CLASP2 CHD3 EPS15L1 GRK3 ANKAR FNIP1 XYLB PLOD1 RIC1 DOCK1 DDR1 ANK3 POLG KSR2 ADGRL1 PARD3B SLITRK3 IDE OGDH CASK EGFR PKP3 SLC16A14 XPNPEP3 PRKAA2 XXYLT1 NT5C2 PRKCI MAPK6 FBXO21 | 2.13e-09 | 1489 | 272 | 36 | 28611215 |
| Pubmed | Reduced AMPK-ACC and mTOR signaling in muscle from older men, and effect of resistance exercise. | 3.66e-09 | 4 | 272 | 4 | 23000302 | |
| Pubmed | Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation. | 3.66e-09 | 4 | 272 | 4 | 24095280 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB4 SRC FASTKD5 ACOX3 MAP3K4 KSR1 NEK1 ACAD11 BRAF DHPS DDX60L PLOD1 KLHL6 DDR1 PLOD3 LCK EGFR CAPN7 PRKAA1 PRKAA2 PRKCD PRKCI MAPK6 MAP3K21 HCK HDAC2 EPHA7 | 3.93e-09 | 910 | 272 | 27 | 36736316 |
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 6.88e-09 | 10 | 272 | 5 | 9069281 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACA DOCK11 SPEG CLASP2 ARHGEF11 TRIP12 RYR3 MAP3K4 MDN1 NBEAL2 DDX23 PLOD1 RIC1 PLOD3 ANK3 MORC2 KIAA0825 CAPN7 IGHMBP2 | 1.76e-08 | 497 | 272 | 19 | 36774506 |
| Pubmed | ABCA2 MFSD6 MARCHF6 PSMC5 CLASP2 TUBGCP2 NCAPG2 ACOX3 KSR1 EPS15L1 GANAB MDN1 GRK2 NBEAL2 PDZD8 DLST ABCD1 SLC25A17 HSP90AB1 DOCK8 ICAM2 IPO9 MTOR IGHMBP2 SMARCA4 TMEM30A DDX39A ENO1 PSD4 | 5.05e-08 | 1168 | 272 | 29 | 19946888 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PRPSAP2 BRPF3 RSAD1 TRAF6 SRC SLC25A30 NCF2 GIT2 MDN1 NBEAL2 DHPS ABCD1 PRMT7 LPAR5 PRAMEF22 SESN3 IDE GRM8 OGDH CAPN11 EGFR CBX6 MTOR GYS2 XXYLT1 TMEM30A ARPIN DAAM2 ILDR1 KAT14 | 5.33e-08 | 1242 | 272 | 30 | 30973865 |
| Pubmed | EPHB4 NMNAT2 ADAM20 SRC KCNH6 NEK1 UBA1 BRAF FGR CAMK1D DNAH10 LCK CAPN11 ADAMTS10 POLR3B EGFR SMARCA4 PRKCD PRKCI MAPK6 HCK HDAC2 | 8.85e-08 | 730 | 272 | 22 | 34857952 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CCT3 SENP3 PSMC5 CHD3 TUBGCP2 TRIP12 MDN1 MORF4L1 DDX23 NIPBL HSP90AB1 DOCK1 DOCK8 HIP1R EXOC5 IPO9 PKP3 SMARCA4 DDX39A | 2.06e-07 | 582 | 272 | 19 | 20467437 |
| Pubmed | TRAF6 SRC MAP3K4 BRAF PKM HSP90AB1 LCK GRM5 EGFR MTOR PRKAA2 APPL1 PRKCD HCK HDAC2 | 2.85e-07 | 371 | 272 | 15 | 25241761 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA CCT3 BMS1 PSMC5 FASTKD5 CLASP2 UBE4A UBA1 GANAB MDN1 PKM DLST NIPBL HSP90AB1 GPD2 ADCY4 DNAH10 GLOD4 IDE GRM1 OGDH IGF2BP1 IPO9 MTOR WDR6 PRKAA2 SMARCA4 PRKCD PRKCI ENO1 EPB41L2 | 3.14e-07 | 1425 | 272 | 31 | 30948266 |
| Pubmed | CDK17 PDE1C CCT3 MYO5B CLASP2 CHD3 ARHGEF11 DLGAP3 EPS15L1 UBA1 GRK2 TTC7B SNAP91 PKM SYN2 DLST HSP90AB1 GPD2 ADCY4 ANK3 DOCK8 ADGRL1 GRM1 GRM5 OGDH NT5DC3 CASK PRKAA1 SMARCA4 HCK EPB41L2 | 3.44e-07 | 1431 | 272 | 31 | 37142655 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | CCT3 PSMC5 EVPL CHD3 KCTD1 TRIP12 RYR1 UBA1 DLST PLCD1 KSR2 HIP1R GLOD4 IDE PKP3 MRPS26 XPNPEP3 PRKCD DDX39A ENO1 EPHA7 | 3.92e-07 | 732 | 272 | 21 | 34732716 |
| Pubmed | PRPSAP1 DYM CCT3 BMS1 PSMC5 FASTKD5 TUBGCP2 NCAPG2 UBE4A GANAB MDN1 DDX23 DLST DDX60L PLOD1 GPD2 PLOD3 DDX60 MRPL45 OGDH IFIT1 GFM2 EXOC5 IGF2BP1 POLR3B IPO9 MTOR WDR6 MRPS26 LTN1 ENO1 | 3.93e-07 | 1440 | 272 | 31 | 30833792 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ACACA CCT3 BMS1 PSMC5 TIPRL EPS15L1 NAA25 UBA1 AGL NAE1 PKM DLST GPNMB PLOD1 HSP90AB1 GPD2 DCPS HIP1R TRMT1 MUC5B GLOD4 IDE OGDH IFIT1 IPO9 MTOR PRKAA1 ARPIN DDX39A ENO1 | 4.12e-07 | 1367 | 272 | 30 | 32687490 |
| Pubmed | ACACA CCT3 PSMC5 FREM1 GANAB AGL FNIP1 PRMT7 DOCK1 PLOD3 MRPL45 MTOR PRKAA1 PRKAA2 PRKCI DDX39A | 4.29e-07 | 437 | 272 | 16 | 20562859 | |
| Pubmed | PRPSAP1 PRPSAP2 CCT3 BMS1 PSMC5 CLASP2 UBA1 ACAD11 CIZ1 PKM DDX23 DLST HSP90AB1 IGF2BP1 MRPS26 XPNPEP3 MAPK6 ENO1 | 4.30e-07 | 551 | 272 | 18 | 34728620 | |
| Pubmed | PRPSAP2 SENP3 SRC FASTKD5 BCS1L NCAPG2 DLST PLOD1 QSOX2 POLG MRPL45 IDE OGDH NT5DC3 MRPS26 XPNPEP3 | 4.43e-07 | 438 | 272 | 16 | 32628020 | |
| Pubmed | 4.47e-07 | 9 | 272 | 4 | 7682059 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 18403125 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 8634424 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 23242808 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 18434746 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 2900138 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.73e-07 | 3 | 272 | 3 | 9204703 | |
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 21881589 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 15618223 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 4.73e-07 | 3 | 272 | 3 | 12213830 | |
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 27996156 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 25239916 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 11159936 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 7959768 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 7635066 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 7876312 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 4.73e-07 | 3 | 272 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 4.73e-07 | 3 | 272 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 4.73e-07 | 3 | 272 | 3 | 10473538 | |
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 22323579 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 16024054 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 9242641 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 18643873 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 4.73e-07 | 3 | 272 | 3 | 4600883 | |
| Pubmed | SENP3 FASTKD5 TUBGCP2 BCS1L UBE4A DDX23 DLST HSP90AB1 GPD2 CASK EXOC5 POLR3B IPO9 WDR6 PRKAA1 LTN1 EPB41L2 HDAC2 | 5.43e-07 | 560 | 272 | 18 | 35241646 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDE1B CCT3 MYO5B PSMC5 EPS15L1 GRK2 SNAP91 PKM HSP90AB1 GPD2 DOCK8 OGDH EHHADH MTOR PRKCD ATP1A4 ENO1 HCK EPB41L2 | 5.49e-07 | 621 | 272 | 19 | 22794259 |
| Pubmed | 5.69e-07 | 39 | 272 | 6 | 33059001 | ||
| Pubmed | 7.24e-07 | 93 | 272 | 8 | 27215380 | ||
| Pubmed | EPHB4 CDK17 BMS1 FASTKD5 CLASP2 BCS1L NCAPG2 EFR3A UBE4A GANAB MDN1 NAE1 DHPS CIZ1 DDX23 PDZD8 DLST PLOD1 PLOD3 ANK3 MRPL45 OGDH CCDC61 CASK EXOC5 EGFR WDR6 MRPS26 PRKCI EPB41L2 EPHA7 | 7.77e-07 | 1487 | 272 | 31 | 33957083 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP1 PRPSAP2 ACACA CCT3 CLASP2 UBA1 GANAB AGL MORF4L1 PKM DDX23 HSF1 PLOD1 NIPBL HSP90AB1 GPD2 PLOD3 INTS7 TRMT1 GLOD4 IGF2BP1 EGFR PKP3 MRPS26 XPNPEP3 PRKAA1 SMARCA4 ENO1 EPB41L2 HDAC2 | 8.41e-07 | 1415 | 272 | 30 | 28515276 |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | PRPSAP1 ACACA TRIP12 AGL NAE1 MORF4L1 DHPS TRMT1 IPO9 SMARCA4 APPL1 | 1.02e-06 | 212 | 272 | 11 | 33462405 |
| Pubmed | ABCA2 TRAF6 TRIP12 ZNF785 RYR3 UBE4A EPS15L1 NAA25 TTC7B MORF4L1 PKM PDZD8 DLST NIPBL HSP90AB1 DOCK3 ANK3 POLG SESN3 CASK POLR3B CELSR3 GUCY1B1 CIAO3 ATRNL1 SMARCA4 APPL1 DAAM2 | 1.18e-06 | 1285 | 272 | 28 | 35914814 | |
| Pubmed | PRPSAP2 ACACA ADGRB2 RYR2 DLGAP3 EPS15L1 UBA1 GRK2 PKM SYN2 DLST HSP90AB1 DOCK3 ANK3 HIP1R ADGRL1 GRM5 OGDH NT5DC3 GUCY1B1 IGHMBP2 APPL1 ENO1 EPB41L2 GABBR1 HDAC2 | 1.25e-06 | 1139 | 272 | 26 | 36417873 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.44e-06 | 71 | 272 | 7 | 28319113 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK17 CCT3 CLASP2 TUBGCP2 EPS15L1 UBA1 GANAB GPATCH11 CIZ1 PKM DDX23 HSF1 HSF2 PLOD1 NIPBL POGK IDE LCK ZNF8 IGF2BP1 MRPS26 SMARCA4 PRKCI DDX39A TOP3A HDAC2 | 1.61e-06 | 1155 | 272 | 26 | 20360068 |
| Pubmed | Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. | 1.72e-06 | 12 | 272 | 4 | 10918587 | |
| Pubmed | MYO5B TRIP12 MDN1 PKM NIPBL HSP90AB1 DDX60 HIP1R PKP3 ENO1 STAG3 HDAC2 | 1.82e-06 | 272 | 272 | 12 | 31010829 | |
| Pubmed | 1.83e-06 | 141 | 272 | 9 | 20056178 | ||
| Pubmed | RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. | 1.88e-06 | 4 | 272 | 3 | 9778343 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.88e-06 | 4 | 272 | 3 | 23413940 | |
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 9607712 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 18094233 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 23482488 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 18206662 | ||
| Pubmed | Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1. | 1.88e-06 | 4 | 272 | 3 | 37079666 | |
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 15254091 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 11052978 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 20221584 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 27249714 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 18040027 | ||
| Pubmed | Acute exercise does not cause sustained elevations in AMPK signaling or expression. | 1.88e-06 | 4 | 272 | 3 | 18614941 | |
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 22504960 | ||
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 9384575 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCT3 MYO5B SRC PSMC5 CHD3 TRIP12 UBA1 GANAB MDN1 CIZ1 PKM DDX23 PLOD1 NIPBL HSP90AB1 GPD2 IGF2BP1 PKP3 XPNPEP3 PRKAA1 SMARCA4 ENO1 EPB41L2 HDAC2 | 2.08e-06 | 1024 | 272 | 24 | 24711643 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | BMS1 PSMC5 EVPL TIPRL NCAPG2 DLGAP3 GANAB ACAD11 AGL DHPS PLOD1 QSOX2 PLOD3 IDE CASK IGF2BP1 MTOR WDR6 PKP3 PRKAA1 PRKAA2 LTN1 FBXO21 | 3.02e-06 | 974 | 272 | 23 | 28675297 |
| Pubmed | CCT3 MYO5B BMS1 PSMC5 CLASP2 TIPRL EFR3A UBA1 GANAB TTC7B DHPS PDZD8 PLOD1 HSP90AB1 GPD2 PLOD3 ANK3 IDE CCDC61 CASK IPO9 EGFR LTN1 PRKCI | 3.14e-06 | 1049 | 272 | 24 | 27880917 | |
| Pubmed | 3.39e-06 | 152 | 272 | 9 | 16009940 | ||
| Pubmed | CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis. | 3.44e-06 | 14 | 272 | 4 | 15707590 | |
| Pubmed | 3.44e-06 | 14 | 272 | 4 | 26941654 | ||
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 3.44e-06 | 14 | 272 | 4 | 29568343 | |
| Pubmed | 3.44e-06 | 14 | 272 | 4 | 12432077 | ||
| Pubmed | CCT3 MYO5B CHD3 TKTL1 EPX TRIP12 RYR2 FER1L6 ABCB4 FRA10AC1 MDN1 SNAP91 PKM DDX23 DLST DNAH8 NIPBL HSP90AB1 ABCB5 OGDH CAPN11 KIAA0825 CIAO3 MAPK6 ATP1A4 DDX39A ENO1 HDAC2 UTP14C | 3.64e-06 | 1442 | 272 | 29 | 35575683 | |
| Pubmed | DOCK11 GIT2 ARHGEF11 EPS15L1 UBA1 GANAB PLOD1 DOCK1 DOCK3 PLEKHG4 DOCK8 GLOD4 PREX2 CASK WDR6 MRPS26 NT5C2 SMARCA4 APPL1 DDX39A EPB41L2 HDAC2 | 3.82e-06 | 916 | 272 | 22 | 32203420 | |
| Pubmed | 4.68e-06 | 5 | 272 | 3 | 22317764 | ||
| Pubmed | Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. | 4.68e-06 | 5 | 272 | 3 | 17922035 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 4.68e-06 | 5 | 272 | 3 | 19011160 | |
| Pubmed | 4.68e-06 | 5 | 272 | 3 | 21220696 | ||
| Pubmed | Antagonistic control of muscle cell size by AMPK and mTORC1. | 4.68e-06 | 5 | 272 | 3 | 21799304 | |
| Pubmed | 4.68e-06 | 5 | 272 | 3 | 29563610 | ||
| Pubmed | 4.68e-06 | 5 | 272 | 3 | 23918386 | ||
| Pubmed | Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. | 4.68e-06 | 5 | 272 | 3 | 19274086 | |
| Pubmed | 4.68e-06 | 5 | 272 | 3 | 16687414 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | SENP3 CHD3 TRIP12 BCS1L NAA25 GANAB MDN1 TTC7B MORF4L1 DDX23 NIPBL INTS7 POLR3B CBX6 SMARCA4 EPB41L2 | 5.56e-06 | 533 | 272 | 16 | 30554943 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK17 TRAF6 MYO5B PSMC5 CLASP2 GIT2 TIPRL NCAPG2 XYLT2 KSR1 NEK1 EPS15L1 UBA1 DHPS CIZ1 HSF1 ANK3 INPP5E EXOC5 IPO9 MTOR IQCB1 XPNPEP3 APPL1 PRKCI MAP3K21 HDAC2 | 6.01e-06 | 1321 | 272 | 27 | 27173435 |
| Interaction | HSP90AA1 interactions | NMNAT2 TRAF6 PSKH1 SENP3 SRC CHD3 KLHL32 JAK3 KSR1 AREL1 UBA1 GRK2 BRAF PKM FNIP1 FGR HSF1 NIPBL ALK HSP90AB1 KLHL6 DDR1 POGK DDX60 KSR2 LCK IFIT1 EGFR GUCY1B1 MTOR IQCB1 PRKAA1 PRKAA2 PRKCD PRKCI MAP3K21 ENO1 PSKH2 HCK NEK11 HDAC2 EPHB1 | 3.98e-08 | 1263 | 269 | 42 | int:HSP90AA1 |
| Interaction | CDC37 interactions | EPHB4 EPHA6 PSKH1 SRC PSMC5 MAP3K4 BRAF PKM FNIP1 PDZD8 FGR ALK HSP90AB1 DDR1 KSR2 LCK EGFR MTOR WDR6 PRKAA1 PRKCI MAP3K21 PSKH2 HCK NEK11 EPHA7 EPHB1 | 1.70e-07 | 645 | 269 | 27 | int:CDC37 |
| Interaction | GRK2 interactions | ACACA SRC GIT2 ITGA2B GRK2 GRK3 HSP90AB1 FPR1 GRM1 EGFR PRKCD | 5.77e-07 | 119 | 269 | 11 | int:GRK2 |
| Interaction | IVNS1ABP interactions | PRPSAP1 PRPSAP2 CCT3 CHD3 EPS15L1 GANAB HSF1 HSP90AB1 ANK3 IGF2BP1 LTN1 ENO1 HCK | 9.46e-07 | 180 | 269 | 13 | int:IVNS1ABP |
| Interaction | HSP90AB1 interactions | TRAF6 EPHA6 CCT3 PSKH1 SENP3 SRC CHD3 TUBGCP2 JAK3 UBA1 GRK2 BRAF PKM FGR HSF1 HSP90AB1 ANK3 LCK IFIT1 EGFR MTOR WDR6 IQCB1 PRKAA1 MAPK6 MAP3K21 ENO1 PSKH2 HCK NEK11 EPB41L2 HDAC2 | 1.86e-06 | 960 | 269 | 32 | int:HSP90AB1 |
| Interaction | SOCS1 interactions | PRPSAP1 PRPSAP2 TRAF6 CCT3 SRC JAK3 AREL1 ALK HSP90AB1 LCK EGFR NT5C2 | 4.80e-06 | 177 | 269 | 12 | int:SOCS1 |
| Interaction | MYCBP2 interactions | NMNAT2 ABCA2 PDE1B CCT3 SENP3 CLASP2 CLSTN2 ARHGEF11 MDN1 HSP90AB1 SESN3 EGFR GUCY1B1 MTOR APPL1 MAPK6 HDAC2 | 6.28e-06 | 355 | 269 | 17 | int:MYCBP2 |
| Interaction | YWHAE interactions | PRPSAP1 PRPSAP2 CDK17 DOCK11 CCR9 SRC CLASP2 GIT2 ITGA2B TRIP12 KSR1 NEK1 DLGAP3 UBA1 BRAF SYN2 DLST HSF1 HSP90AB1 DOCK8 INPP5E KSR2 PARD3B CASK IGF2BP1 IPO9 MTOR CAPN7 PRKAA1 NT5C2 APPL1 PRKCI MAP3K21 DDX39A EPB41L2 PSD4 | 1.24e-05 | 1256 | 269 | 36 | int:YWHAE |
| Interaction | GPR182 interactions | ABCA2 DYM MAOB FASTKD5 TUBGCP2 WLS NCAPG2 MDN1 NBEAL2 ABCD1 SLC25A17 QSOX2 PLEKHG4 POLG HIP1R EXOC5 MTOR LTN1 TMEM30A | 1.27e-05 | 455 | 269 | 19 | int:GPR182 |
| Interaction | YWHAZ interactions | CDK17 PDE1B DOCK11 SPEG CLASP2 ITGA2B TRIP12 MAP3K4 KSR1 NEK1 UBA1 BRAF NBEAL2 SYN2 DLST HSF1 HSP90AB1 INPP5E KSR2 HIP1R PARD3B LCK EXOC5 IPO9 EGFR MTOR PRKAA1 PRKAA2 APPL1 PRKCD PRKCI MAP3K21 ENO1 EPB41L2 GABBR1 HDAC2 PSD4 | 1.49e-05 | 1319 | 269 | 37 | int:YWHAZ |
| Interaction | MAPK15 interactions | 2.04e-05 | 63 | 269 | 7 | int:MAPK15 | |
| Interaction | NPY2R interactions | 2.78e-05 | 66 | 269 | 7 | int:NPY2R | |
| Interaction | TRIM28 interactions | PRPSAP1 PRPSAP2 ZNF486 ACACA CCT3 SENP3 SRC PSMC5 CLASP2 CHD3 TRIP12 NCAPG2 ZNF785 MAP3K4 AGL PKM DLST DNAH8 NIPBL ZNF607 POGK TRMT1 MORC2 ZNF8 IGF2BP1 POLR3B EGFR MTOR MRPS26 IQCB1 PRKAA1 ZNF256 LTN1 SMARCA4 PRKCI ZNF324B DDX39A TOP3A EPB41L2 | 3.19e-05 | 1474 | 269 | 39 | int:TRIM28 |
| Interaction | PRKCG interactions | 3.61e-05 | 121 | 269 | 9 | int:PRKCG | |
| Interaction | EPHA2 interactions | CDK17 ACACA EPHA6 SRC UBE4A GANAB GRK2 TTC7B ALK DDR1 ANK3 ABCB5 ADGRL1 PARD3B LCK GRM1 CASK EGFR WDR6 APPL1 PRKCI HCK EPB41L2 EPHA7 | 3.80e-05 | 719 | 269 | 24 | int:EPHA2 |
| Interaction | DCAF7 interactions | CDK17 BRPF3 CCT3 CLASP2 JAK3 UBE4A EPS15L1 HSF1 NIPBL HSP90AB1 INPP5E IGF2BP1 EGFR CBX6 PRKAA2 PRKCI | 3.83e-05 | 368 | 269 | 16 | int:DCAF7 |
| Interaction | PRKCZ interactions | EPHB4 PRPSAP2 TRAF6 SRC PSMC5 UBA1 GANAB PKM HSP90AB1 DDR1 MRPL45 GRM5 EGFR MTOR APPL1 PRKCD PRKCI | 4.24e-05 | 412 | 269 | 17 | int:PRKCZ |
| Interaction | FKBP5 interactions | EPHB4 PSKH1 NCAPG2 JAK3 BRAF FGR HSF1 HSP90AB1 KSR2 IDE POLR3B EGFR WDR6 PRKAA1 MAP3K21 PSKH2 NEK11 | 4.50e-05 | 414 | 269 | 17 | int:FKBP5 |
| Interaction | PRKAB1 interactions | 5.85e-05 | 100 | 269 | 8 | int:PRKAB1 | |
| Interaction | HCK interactions | PRPSAP1 PRPSAP2 SRC CHD3 FGR HSP90AB1 PLEKHG4 LCK CASK EGFR HCK | 5.96e-05 | 193 | 269 | 11 | int:HCK |
| Interaction | FKBP1B interactions | 6.12e-05 | 32 | 269 | 5 | int:FKBP1B | |
| Interaction | RHOB interactions | EPHB4 DOCK11 SRC BMS1 FASTKD5 WLS ARHGEF11 EFR3A UBA1 GANAB MDN1 TTC7B DOCK1 ANK3 HIP1R ADGRL1 PARD3B CASK EGFR WDR6 APPL1 PRKCD PRKCI MAP3K21 EPB41L2 EPHA7 | 6.34e-05 | 840 | 269 | 26 | int:RHOB |
| Interaction | EFNA1 interactions | 7.23e-05 | 103 | 269 | 8 | int:EFNA1 | |
| Interaction | RAC1 interactions | EPHB4 PRPSAP1 PRPSAP2 TRAF6 MYO5B DOCK11 SRC NCF2 GIT2 ARHGEF11 MAP3K4 EFR3A MDN1 PKM PDZD8 DOCK1 DOCK3 ANK3 PLEKHG4 DOCK8 ADGRL1 PREX2 CASK EGFR MTOR WDR6 IQCB1 PRKCD PRKCI EPHA7 | 9.18e-05 | 1063 | 269 | 30 | int:RAC1 |
| Interaction | TAMALIN interactions | 1.03e-04 | 19 | 269 | 4 | int:TAMALIN | |
| Cytoband | 6p12 | 1.32e-04 | 17 | 272 | 3 | 6p12 | |
| Cytoband | 3p22-p21.3 | 2.08e-04 | 4 | 272 | 2 | 3p22-p21.3 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 6.17e-07 | 8 | 178 | 4 | 281 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 9.38e-07 | 3 | 178 | 3 | 287 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 8.42e-06 | 14 | 178 | 4 | 1095 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 9.25e-06 | 5 | 178 | 3 | 1157 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.82e-05 | 181 | 178 | 9 | 694 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.63e-03 | 24 | 178 | 3 | 654 | |
| GeneFamily | Phosphodiesterases | 1.63e-03 | 24 | 178 | 3 | 681 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | PDE1B WDR81 NCF2 RYR1 PRMT7 GPD2 POLG HIP1R ASL CD70 MAPK6 EPB41L2 | 1.26e-06 | 199 | 272 | 12 | M3912 |
| Coexpression | FIRESTEIN_PROLIFERATION | 1.40e-06 | 166 | 272 | 11 | M5354 | |
| Coexpression | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP | 6.85e-06 | 45 | 272 | 6 | M104 | |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN | 7.32e-06 | 197 | 272 | 11 | M8227 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | EPHB4 CCT3 JAK3 NAA25 MDN1 DHPS HSP90AB1 NDST2 TRMT1 ENO1 HDAC2 | 7.32e-06 | 197 | 272 | 11 | M7458 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | CCT3 SRC CHD3 ARHGEF11 TMEM52B FER1L6 KCNH6 KSR1 CIZ1 PKM HSF2 HSP90AB1 DOCK3 ZNF607 PARD3B CAPN11 IPO9 CELSR3 CBX6 XXYLT1 SMARCA4 ATP1A4 EPB41L2 HDAC2 RASD2 | 7.34e-06 | 891 | 272 | 25 | M45033 |
| Coexpression | FINETTI_BREAST_CANCER_KINOME_GREEN | 1.87e-05 | 16 | 272 | 4 | M12692 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RSAD1 ACACA SENP3 MARCHF6 DHDDS RYR3 SNX13 ABCB4 EFR3A UBE4A MDN1 GRK3 NAE1 CIZ1 HSF2 NIPBL INTS7 NDST2 GLOD4 EXOC5 CAPN7 LTN1 NT5C2 APPL1 PRKCD PRKCI ENO1 TOP3A EPHB1 | 2.84e-05 | 1215 | 272 | 29 | M41122 |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP | PRPSAP2 NCF2 ABCD1 FPR1 LCK ADAMTS10 TGFBI PRKCD EPB41L2 RASD2 | 4.90e-05 | 200 | 272 | 10 | M7234 |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP | MARCHF6 SLC25A30 FASTKD5 TUBGCP2 PRMT7 ADGRG3 CAMK1D CELSR3 CIAO3 KAT14 | 4.90e-05 | 200 | 272 | 10 | M7805 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | EPHA6 NDST4 DNAH8 IQCM ALK ABCB5 GRM1 GRM5 GRM7 TMEM132D ATRNL1 | 1.98e-09 | 148 | 272 | 11 | d6ac5972267254651dfbe16bb4e9a62228093cc7 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | EPHA6 NDST4 RYR1 RYR2 DNAH8 IQCM ALK GRM5 GRM7 TMEM132D MYO16 | 4.22e-09 | 159 | 272 | 11 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARPP21 PDE1B FSTL4 RYR1 DLGAP3 FPR1 ADGRL1 GPR88 GRM5 GABBR1 RASD2 | 1.46e-08 | 179 | 272 | 11 | a3922476f33d2e4137a12dbda21a1703dff79684 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-08 | 195 | 272 | 11 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DOCK11 NCF2 TTC7B DDX60L GPNMB FGR KLHL6 CAMK1D DOCK8 TGFBI HCK | 4.33e-08 | 199 | 272 | 11 | 7ee2805fd9143eba11bf6832267b62189683608b |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARPP21 PDE1B FSTL4 RYR1 DLGAP3 ADGRL1 GPR88 ATRNL1 GABBR1 RASD2 | 1.54e-07 | 178 | 272 | 10 | 1bddbc083c36657bd6910f7466126ab325e88176 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARPP21 PDE1B FSTL4 RYR1 DLGAP3 ADGRL1 GPR88 ATRNL1 GABBR1 RASD2 | 1.54e-07 | 178 | 272 | 10 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | NMNAT2 SPEG SRC CLSTN2 RYR2 LMCD1 HBEGF S1PR3 GUCY1B1 EGFLAM | 1.63e-07 | 179 | 272 | 10 | f5bb4d3a27d56698473219970e764084096cc582 |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | NMNAT2 SPEG SRC CLSTN2 RYR2 LMCD1 HBEGF S1PR3 GUCY1B1 EGFLAM | 1.63e-07 | 179 | 272 | 10 | fa03ec3cc0132f977b4cb28e7b23789732375183 |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NMNAT2 SRC CLSTN2 LMCD1 HBEGF S1PR3 GUCY1B1 PDE8B DAAM2 EGFLAM | 1.90e-07 | 182 | 272 | 10 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NMNAT2 SRC CLSTN2 LMCD1 HBEGF S1PR3 GUCY1B1 PDE8B DAAM2 EGFLAM | 1.90e-07 | 182 | 272 | 10 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-07 | 184 | 272 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-07 | 184 | 272 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-07 | 184 | 272 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | CDK17 ARPP21 PDE1B MYO5B ADGRB2 GPR88 GRM5 GRM7 FAM135B RASD2 | 2.56e-07 | 188 | 272 | 10 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | NMNAT2 SRC CLSTN2 GRK3 LMCD1 HBEGF S1PR3 PREX2 GUCY1B1 EGFLAM | 2.56e-07 | 188 | 272 | 10 | e7681efb4d2de7f1d8a89552fff76a829376bf1b |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NMNAT2 CLSTN2 LMCD1 HBEGF S1PR3 PREX2 GUCY1B1 PDE8B EGFLAM EPB41L2 | 2.83e-07 | 190 | 272 | 10 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NMNAT2 CLSTN2 LMCD1 HBEGF S1PR3 PREX2 GUCY1B1 PDE8B EGFLAM EPB41L2 | 2.83e-07 | 190 | 272 | 10 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.27e-07 | 193 | 272 | 10 | d9bb77214bb92e8392cf74e3bfdf177a96fd71ea | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARPP21 ADGRB2 FSTL4 RYR2 DLGAP3 SYN2 ADGRL1 SLITRK3 GRM1 GRM5 | 3.27e-07 | 193 | 272 | 10 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARPP21 ADGRB2 FSTL4 RYR2 DLGAP3 SYN2 ADGRL1 SLITRK3 GRM1 GRM5 | 3.27e-07 | 193 | 272 | 10 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARPP21 ADGRB2 FSTL4 RYR2 DLGAP3 SYN2 ADGRL1 SLITRK3 GRM1 GRM5 | 3.27e-07 | 193 | 272 | 10 | 0c652ebe22ce5d2927599dd97ef1920547858395 |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.13e-07 | 198 | 272 | 10 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.13e-07 | 198 | 272 | 10 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 4.13e-07 | 198 | 272 | 10 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-07 | 200 | 272 | 10 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-07 | 157 | 272 | 9 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 173 | 272 | 9 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NMNAT2 CLSTN2 LMCD1 HBEGF S1PR3 PREX2 GUCY1B1 EGFLAM EPB41L2 | 1.23e-06 | 173 | 272 | 9 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NMNAT2 CLSTN2 LMCD1 HBEGF S1PR3 PREX2 GUCY1B1 EGFLAM EPB41L2 | 1.23e-06 | 173 | 272 | 9 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 175 | 272 | 9 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 175 | 272 | 9 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 175 | 272 | 9 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 175 | 272 | 9 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-06 | 178 | 272 | 9 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-06 | 178 | 272 | 9 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 180 | 272 | 9 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 180 | 272 | 9 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 180 | 272 | 9 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 180 | 272 | 9 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 180 | 272 | 9 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 181 | 272 | 9 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-06 | 181 | 272 | 9 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 182 | 272 | 9 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 182 | 272 | 9 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-06 | 184 | 272 | 9 | c451acfcd8fe28c1f4b1ea334b1129fa84a15c42 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.06e-06 | 184 | 272 | 9 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.15e-06 | 185 | 272 | 9 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-06 | 186 | 272 | 9 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-06 | 139 | 272 | 8 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 187 | 272 | 9 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 187 | 272 | 9 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 187 | 272 | 9 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-06 | 188 | 272 | 9 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-06 | 190 | 272 | 9 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-06 | 190 | 272 | 9 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | ASK440-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.68e-06 | 142 | 272 | 8 | ea694a907eaa46c55665692cb830870281700e40 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 191 | 272 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 2.79e-06 | 191 | 272 | 9 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 2.91e-06 | 192 | 272 | 9 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.04e-06 | 193 | 272 | 9 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.17e-06 | 194 | 272 | 9 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 3.31e-06 | 195 | 272 | 9 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 3.31e-06 | 195 | 272 | 9 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.45e-06 | 196 | 272 | 9 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-06 | 197 | 272 | 9 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-06 | 197 | 272 | 9 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-06 | 197 | 272 | 9 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-06 | 197 | 272 | 9 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.60e-06 | 197 | 272 | 9 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | PCW_13-14-Hematologic_Myeloid|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.75e-06 | 198 | 272 | 9 | d42fce8e547dc97f3cf144ab65483a1b11ace267 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 198 | 272 | 9 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.75e-06 | 198 | 272 | 9 | 1d242fbe4ae3628103f6b6f910a7641bb1b75266 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.75e-06 | 198 | 272 | 9 | f3a12a7e23bb4ff6e82fee675dbc090d99587f69 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 198 | 272 | 9 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.04e-06 | 150 | 272 | 8 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 4.07e-06 | 200 | 272 | 9 | bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60 | |
| ToppCell | Sigmoid-Macrophage-LYVE1_Macrophage|Sigmoid / Region, Cell class and subclass | 4.07e-06 | 200 | 272 | 9 | 851a1b372ddbec522829069e69ed36a1f4832131 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-06 | 152 | 272 | 8 | 931c10245cde9b3290224cc1da46b2bf300b9ac2 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 6.80e-06 | 161 | 272 | 8 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 161 | 272 | 8 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 161 | 272 | 8 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 7.45e-06 | 163 | 272 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-06 | 164 | 272 | 8 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-06 | 164 | 272 | 8 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-06 | 168 | 272 | 8 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 169 | 272 | 8 | 2d3618f78484bd3508b7bdae3a0d0183cdae5057 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 170 | 272 | 8 | f08aa6168ff0c20b2083dbf588dd3294e3d9580e | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-05 | 171 | 272 | 8 | 4ad28ecfde3d529a09b80be908c446bd5274518e | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 171 | 272 | 8 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-05 | 171 | 272 | 8 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 172 | 272 | 8 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 172 | 272 | 8 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 173 | 272 | 8 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 173 | 272 | 8 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 173 | 272 | 8 | 50b25b7f8f29b60c22782a4492fe4b089fe7d69d | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 173 | 272 | 8 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 175 | 272 | 8 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-05 | 177 | 272 | 8 | 44c38e572a9e9678c2dbb3e8b4748e7e28d404b7 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 179 | 272 | 8 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| Drug | NSC618487 | EPHA6 SRC NCF2 ITGA2B MAP3K4 JAK3 GRK2 GRK3 SPHK1 PLCD1 XYLB FGR HSF1 HSF2 ADCY4 CAMK1D POGK HBEGF ABCB5 FPR1 LCK GRM1 GRM5 GRM7 GRM8 S1PR3 TGFBI EGFR TMEM132D GYS2 PRKAA1 SLC6A5 PRKCD PRKCI MAPK6 HCK EPHA7 EPHB1 | 2.81e-11 | 933 | 269 | 38 | CID000005279 |
| Drug | vandetanib | EPHB4 EPHA6 SRC MAP3K4 BRAF FGR LCK EGFR MTOR PRKAA1 HCK EPHA7 EPHB1 | 1.64e-10 | 99 | 269 | 13 | CID003081361 |
| Drug | sunitinib | EPHB4 EPHA6 SRC MAP3K4 BRAF FGR CAMK1D LCK EGFR MTOR PRKAA1 HCK EPHA7 EPHB1 | 4.75e-10 | 130 | 269 | 14 | CID005329102 |
| Drug | magnesium | EPHB4 NMNAT2 PDE1B MYO5B SRC DHDDS ITGA2B EPX RYR1 RYR2 RYR3 ABCB4 GRK2 GRK3 CLCNKA SPHK1 PKM DLST ALDH3A1 DNAH8 ALK HSP90AB1 ADCY4 DNAH10 ABCB5 LCK GRM1 GRM5 OGDH GFM2 POLR3B EGFR GUCY1B1 GYS2 XPNPEP3 NT5C2 PRKCD PRKCI ENO1 HCK NEK11 TOP3A | 4.98e-09 | 1325 | 269 | 42 | CID000000888 |
| Drug | phosphine oxide | ACACA RYR1 RYR2 RYR3 KCNH6 GRK2 CLCN1 GRK3 GRM7 NT5C2 PRKCD PRKCI | 5.30e-09 | 107 | 269 | 12 | CID000166931 |
| Drug | AMP group | PRPSAP2 PDE1C NMNAT2 DYM ACACA PDE1B ACOX3 UBA1 GRK2 GRK3 PKM FNIP1 SLC25A17 ADCY4 CAMK1D ADGRL1 OGDH MTOR ASL GYS2 PRKAA1 PRKAA2 NT5C2 PRKCD PRKCI ENO1 | 6.64e-09 | 579 | 269 | 26 | CID000000224 |
| Drug | ponatinib | 7.14e-09 | 68 | 269 | 10 | ctd:C545373 | |
| Drug | C070379 | SRC RYR1 RYR2 RYR3 GRK2 GRK3 HSF1 HSF2 GRM1 GRM5 GRM7 GRM8 OGDH S1PR3 MAPK6 | 1.61e-08 | 199 | 269 | 15 | CID003034747 |
| Drug | lavendustin A | SRC RYR1 RYR2 RYR3 GRK2 GRK3 SYN2 HBEGF LCK GRM5 EGFR PRKCD PRKCI HCK | 1.71e-08 | 171 | 269 | 14 | CID000003894 |
| Drug | GF109203X | SRC KCNH6 GRK2 GRK3 PLCD1 HSF1 ADCY4 HBEGF LCK GRM1 GRM5 GRM7 GRM8 S1PR3 EGFR MTOR PRKCD PRKCI MAPK6 | 2.76e-08 | 341 | 269 | 19 | CID000002396 |
| Drug | glutamate | PRPSAP2 NMNAT2 MAOB DHDDS ARHGEF11 BCS1L RYR1 RYR2 RYR3 MDN1 CLCN1 CLCNKA PKM SYN2 PLCD1 ALDH3A1 PLOD1 GPD2 ADCY4 LPAR5 ABCB5 IDE GRM1 GRM5 GRM7 GRM8 OGDH MTOR ASL IGHMBP2 SLC6A5 PRKCD PRKCI | 4.26e-08 | 962 | 269 | 33 | CID000000611 |
| Drug | orthovanadate | PDE1C PDE1B SRC DHDDS RYR1 ABCB4 GRK2 GRK3 ACAD11 DLST ADCY4 HBEGF ABCB5 LCK GRM5 EGFR PDE8B GYS2 PRKCD PRKCI MAPK6 | 5.97e-08 | 435 | 269 | 21 | CID000061672 |
| Drug | D-myo-inositol-1,4,5-triphosphate | SRC MARCHF6 RYR1 RYR2 RYR3 GRK2 GRK3 PLCD1 ADCY4 ANK3 HBEGF FPR1 LCK GRM1 GRM5 GRM7 GRM8 S1PR3 EGFR MTOR PRKCD PRKCI MAPK6 HCK | 8.15e-08 | 568 | 269 | 24 | CID000000806 |
| Drug | N-methyl-DL-aspartic acid | MAOB SRC RYR1 RYR2 RYR3 GRK2 GRK3 SYN2 XYLB HSF1 PLOD1 LCK GRM1 GRM5 GRM7 GRM8 OGDH CASK GUCY1B1 MTOR IGHMBP2 SLC6A5 PRKCD PRKCI MAPK6 | 2.97e-07 | 655 | 269 | 25 | CID000004376 |
| Drug | amphetamine | ACACA MAOB GRK2 GRK3 SYN2 XYLB ADCY4 CAMK1D LCK GRM1 GRM5 GRM7 GRM8 SLC6A5 PRKCD PRKCI | 3.05e-07 | 284 | 269 | 16 | CID000003007 |
| Drug | VX-745 | 3.77e-07 | 25 | 269 | 6 | CID003038525 | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | ABCA2 ARHGEF11 GRK3 CIZ1 HSF2 GPD2 EXOC5 EGFR CIAO3 CAPN7 PKP3 IGHMBP2 EPHA7 | 5.11e-07 | 192 | 269 | 13 | 4342_DN |
| Drug | AC1L1KS5 | RYR1 RYR2 RYR3 GRK2 GRK3 SNAP91 PLCD1 ADCY4 LPAR5 FPR1 GRM1 GRM5 GRM7 GRM8 PRKCD PRKCI MAPK6 | 5.42e-07 | 334 | 269 | 17 | CID000005631 |
| Drug | bosutinib | 5.63e-07 | 42 | 269 | 7 | CID005328940 | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | MAOB SPEG CCR9 EVPL CLSTN2 WLS ABCD1 CAMK1D MUC5B GRM1 IFIT1 XPNPEP3 TOP3A | 6.10e-07 | 195 | 269 | 13 | 4817_UP |
| Drug | novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A | ACACA DHDDS FASTKD5 CHD3 AGL DHPS CIZ1 SLC25A17 POLG HIP1R TRMT1 LTN1 PRKCD | 7.25e-07 | 198 | 269 | 13 | 576_DN |
| Drug | vanadyl | PDE1C PDE1B SRC DHDDS GRK2 GRK3 HSF1 DNAH8 DNAH10 LCK EGFR PDE8B PRKCD PRKCI MAPK6 LRIT1 | 8.61e-07 | 307 | 269 | 16 | CID000061671 |
| Drug | EKB-569 | 9.01e-07 | 87 | 269 | 9 | CID006445562 | |
| Drug | cis-MCG-I | 1.29e-06 | 8 | 269 | 4 | CID003035584 | |
| Drug | myo-inositol | ACACA SRC RYR1 RYR2 RYR3 MAP3K4 GRK2 GRK3 SNAP91 PLCD1 ADCY4 LPAR5 HBEGF INPP5E FPR1 LCK GRM1 GRM5 GRM7 GRM8 S1PR3 EGFR MTOR PRKCD PRKCI MAPK6 HCK | 1.39e-06 | 811 | 269 | 27 | CID000000892 |
| Drug | phorbol 12,13-diacetate | 1.45e-06 | 48 | 269 | 7 | CID000072293 | |
| Drug | cis-diammineplatinum(II | 1.63e-06 | 3 | 269 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.63e-06 | 3 | 269 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 1.63e-06 | 3 | 269 | 3 | CID000127713 | |
| Drug | aminodantrolene | 1.63e-06 | 3 | 269 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.63e-06 | 3 | 269 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.63e-06 | 3 | 269 | 3 | CID005748312 | |
| Drug | 1-Butanol | 1.71e-06 | 70 | 269 | 8 | ctd:D020001 | |
| Drug | Adenosine triphosphate | 2.18e-06 | 33 | 269 | 6 | DB00171 | |
| Drug | mM PEP | 2.29e-06 | 9 | 269 | 4 | CID005311462 | |
| Drug | AC1N21PP | 2.29e-06 | 9 | 269 | 4 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 2.29e-06 | 9 | 269 | 4 | CID000107216 | |
| Drug | lysosphingomyelin | RYR1 RYR2 RYR3 MAP3K4 SPHK1 PLCD1 LPAR5 S1PR3 PRKCD PRKCI MAPK6 | 3.35e-06 | 160 | 269 | 11 | CID000005263 |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | ABCA2 EVPL CHD3 NBEAL2 HBEGF ADGRL1 OGDH ZNF8 MLH3 PDE8B ARPIN ZNF324B | 3.62e-06 | 194 | 269 | 12 | 5630_DN |
| Drug | phorbol acetate myristate | SRC NCF2 ITGA2B EPX RYR1 RYR2 RYR3 ABCB4 GRK2 GRK3 BRAF SPHK1 PKM PLCD1 XYLB FGR ADCY4 CAMK1D LPAR5 HBEGF POLG FPR1 ICAM2 LCK GRM1 S1PR3 TGFBI POLR3B EGFR TMEM132D MTOR CD40LG PRKCD PRKCI MAPK6 HCK TOP3A | 3.69e-06 | 1399 | 269 | 37 | CID000004792 |
| Drug | adenosine 3',5'-cyclic phosphate | PDE1C ACACA PDE1B GRK2 CLCN1 GRK3 BRAF CLCNKA PKM SYN2 PLCD1 XYLB ADCY4 HBEGF GRM1 GRM5 GRM7 GRM8 TGFBI GUCY1B1 PDE8B GYS2 CD40LG NT5C2 PRKCD PRKCI MAPK6 ATP1A4 | 3.76e-06 | 907 | 269 | 28 | CID000000274 |
| Drug | NS-105 | 3.78e-06 | 10 | 269 | 4 | CID000198695 | |
| Drug | caffeine | PDE1C DYM PDE1B RYR1 RYR2 RYR3 GRK2 GRK3 PLCD1 ADCY4 GRM1 GRM5 GRM7 GRM8 TGFBI TMEM132D PDE8B LTN1 NT5C2 PRKCI NEK11 | 3.80e-06 | 562 | 269 | 21 | CID000002519 |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A | ACACA PSKH1 SENP3 CHD3 GIT2 AREL1 CIZ1 NIPBL TRMT1 OGDH WDR6 SMARCA4 | 3.82e-06 | 195 | 269 | 12 | 1605_DN |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | TSNAXIP1 ARHGEF11 RYR2 PLCD1 GPD2 POLG LHX6 PREX2 CELSR3 EGFR XPNPEP3 TOP3A | 3.82e-06 | 195 | 269 | 12 | 2283_DN |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | SENP3 SRC GIT2 XYLT2 EPS15L1 BRAF PLCD1 HSP90AB1 POLG CASK PRKAA2 ENO1 | 3.82e-06 | 195 | 269 | 12 | 6583_UP |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SRC ADGRB2 CHD3 GIT2 NBEAL2 CIZ1 PRMT7 HIP1R MUC5B GRM1 IFIT1 SMARCA4 | 3.82e-06 | 195 | 269 | 12 | 4813_UP |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | EVPL CLSTN2 ARHGEF11 SNX13 NBEAL2 CIZ1 ALDH3A1 CAMK1D MORC2 IGHMBP2 SMARCA4 PRKCD | 4.02e-06 | 196 | 269 | 12 | 4833_UP |
| Drug | imatinib | EPHB4 SRC EVPL GIT2 JAK3 BRAF SPHK1 FGR ALK DDR1 ABCB5 LCK TGFBI EGFR MTOR HCK EPHA7 EPHB1 | 4.08e-06 | 430 | 269 | 18 | CID000005291 |
| Drug | gamma-aminobutyric acid | ACACA MAOB BCS1L RYR1 RYR2 RYR3 CLCN1 CLCNKA SYN2 ALDH3A1 PLOD1 GRM1 GRM5 LHX6 GRM7 GRM8 OGDH SLC6A5 GABBR1 | 4.11e-06 | 474 | 269 | 19 | CID000000119 |
| Drug | H2O2 | MAOB SRC NCF2 EPX BCS1L RYR1 ACOX3 RYR2 RYR3 GRK2 CLCN1 GRK3 CLCNKA PLCD1 ABCD1 ALDH3A1 HSF1 PLOD1 HSP90AB1 GPD2 ADCY4 HBEGF POLG SESN3 LCK OGDH EGFR EHHADH MTOR PRKCD PRKCI MAPK6 ENO1 | 4.32e-06 | 1183 | 269 | 33 | CID000000784 |
| Drug | 3-(1H-pyrrole-2-carboxylate | RYR1 RYR2 RYR3 GRK2 GRK3 XYLB GRM1 GRM5 GRM7 GRM8 GUCY1B1 PRKCD PRKCI | 4.44e-06 | 233 | 269 | 13 | CID000005114 |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; PC3; HT_HG-U133A | EPHB4 PDE1C TRAF6 PSKH1 EVPL MAGEF1 XYLT2 EPS15L1 CIZ1 ADGRL1 SMARCA4 APPL1 | 4.47e-06 | 198 | 269 | 12 | 6294_DN |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | CHD3 DHPS CIZ1 PRMT7 ANK3 LMCD1 OGDH EXOC5 MLH3 PRKCD TOP3A EPB41L2 | 4.47e-06 | 198 | 269 | 12 | 5467_DN |
| Drug | AC1L1G9T | SRC EVPL JAK3 GRK2 GRK3 FGR HSF2 HSP90AB1 DDR1 HBEGF LCK TGFBI EGFR MTOR PRKCD PRKCI MAPK6 HCK | 4.49e-06 | 433 | 269 | 18 | CID000003591 |
| Drug | arabinosyladenine | EPHB4 PDE1C ADAT3 PDE1B ITGA2B RYR1 RYR2 RYR3 GRK2 GRK3 PKM GPD2 ADCY4 GRM1 GRM5 GRM7 GRM8 POLR3B GUCY1B1 PDE8B PRKAA2 NT5C2 PRKCD PRKCI MAPK6 | 4.51e-06 | 762 | 269 | 25 | CID000000191 |
| Drug | AC1MU1S9 | PDE1C CCR9 SRC NCF2 JAK3 GRK2 GRK3 SYN2 PLCD1 HSF1 ADCY4 CAMK1D HBEGF FPR1 LCK OGDH GUCY1B1 CD40LG PRKCD PRKCI MAPK6 | 4.99e-06 | 572 | 269 | 21 | CID000003733 |
| Drug | cyclobutylene AP5 | 5.89e-06 | 11 | 269 | 4 | CID000126582 | |
| Drug | N,N-dimethyl-D-erythro-sphingosine | 6.28e-06 | 83 | 269 | 8 | CID000004285 | |
| Drug | AC1L45LU | SRC EVPL KSR1 BRAF XYLB HSF1 ALK HSP90AB1 ABCB5 EGFR MTOR MAPK6 | 6.38e-06 | 205 | 269 | 12 | CID000151069 |
| Drug | PCB74 | 6.47e-06 | 4 | 269 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 6.47e-06 | 4 | 269 | 3 | CID006444275 | |
| Drug | SC 38249 | 6.47e-06 | 4 | 269 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 6.47e-06 | 4 | 269 | 3 | CID000035682 | |
| Drug | suramin | NCAPG2 RYR1 ACOX3 GRK2 SPHK1 LPAR5 POLG S1PR3 EGFR PRKCD PRKCI MAPK6 | 7.04e-06 | 207 | 269 | 12 | CID000005360 |
| Drug | zaprinast | 7.12e-06 | 141 | 269 | 10 | CID000005722 | |
| Drug | BAPTA | SRC EPX RYR1 RYR2 RYR3 GRK2 GRK3 HSF1 GRM1 GRM5 GRM7 GRM8 PRKCD PRKCI MAPK6 | 8.02e-06 | 324 | 269 | 15 | CID000104751 |
| Drug | AC1LD8Z3 | 8.19e-06 | 86 | 269 | 8 | CID000644309 | |
| Drug | 9-beta-D-arabinofuranosylguanine | PDE1C PDE1B SRC DHDDS NCF2 SNX13 GRK2 GRK3 PLCD1 DOCK1 ADCY4 DCPS LPAR5 POLG FPR1 TRMT1 S1PR3 GFM2 EXOC5 GUCY1B1 TMEM132D MTOR PDE8B NT5C2 PRKCD PRKCI | 8.66e-06 | 843 | 269 | 26 | CID000000765 |
| Drug | AMN082 | 8.75e-06 | 12 | 269 | 4 | CID001894360 | |
| Drug | nimodipine | 9.12e-06 | 145 | 269 | 10 | CID000004497 | |
| Drug | DPCPX | 1.07e-05 | 117 | 269 | 9 | CID000001329 | |
| Drug | BAPTA-AM | RYR1 RYR3 XYLB ADCY4 GRM1 GRM5 GRM8 OGDH S1PR3 EGFR TMEM132D PRKCD PRKCI MAPK6 | 1.13e-05 | 293 | 269 | 14 | CID000002293 |
| Drug | HA1 100 | 1.15e-05 | 90 | 269 | 8 | CID003064778 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.25e-05 | 91 | 269 | 8 | CID000002207 | |
| Drug | Mspg | 1.25e-05 | 13 | 269 | 4 | CID003964410 | |
| Drug | MSOPPE | 1.25e-05 | 13 | 269 | 4 | CID005311463 | |
| Drug | AC1NSKBB | 1.25e-05 | 13 | 269 | 4 | CID005311256 | |
| Drug | AC1L1DW2 | SENP3 SRC RYR2 GRK2 GRK3 PKM HSP90AB1 PLEKHG4 CAPN11 CAPN7 PRKCD | 1.41e-05 | 186 | 269 | 11 | CID000002532 |
| Drug | aspartate | DHDDS MDN1 CLCN1 CLCNKA AGL PKM DLST PLOD1 GPD2 PLOD3 IDE GRM1 GRM5 GRM7 GRM8 OGDH ASL IGHMBP2 HTR3B | 1.44e-05 | 518 | 269 | 19 | CID000000424 |
| Drug | phorbol 12-myristate | SRC NCF2 ITGA2B EPX GRK2 GRK3 SPHK1 FPR1 LCK GRM7 PRKCD PRKCI MAPK6 | 1.50e-05 | 261 | 269 | 13 | CID000107854 |
| Drug | DMeOB | 1.60e-05 | 5 | 269 | 3 | CID002061047 | |
| Drug | LY393675 | 1.60e-05 | 5 | 269 | 3 | CID005311262 | |
| Drug | tyrphostin B52 | 1.60e-05 | 5 | 269 | 3 | CID005328773 | |
| Drug | cysteine sulfinic acid | 1.62e-05 | 46 | 269 | 6 | CID000000109 | |
| Drug | isocitrate | 1.73e-05 | 156 | 269 | 10 | CID000001198 | |
| Drug | MTPG | 1.74e-05 | 14 | 269 | 4 | CID005311456 | |
| Drug | 2-methyl-6-styrylpyridine | 1.74e-05 | 14 | 269 | 4 | CID000235382 | |
| Drug | bisindolylmaleimide V | 1.75e-05 | 28 | 269 | 5 | CID000002400 | |
| Drug | (2S,3R)-Sphingosine | GIT2 RYR1 RYR2 RYR3 GRK2 GRK3 SPHK1 DHPS PLCD1 LPAR5 ICAM2 S1PR3 EGFR PRKCD PRKCI MAPK6 | 1.75e-05 | 389 | 269 | 16 | CID000001104 |
| Drug | AC1L1JYL | SRC GIT2 GRK2 GRK3 SPHK1 DHPS PLCD1 LPAR5 HBEGF LCK S1PR3 EGFR MTOR PRKCD PRKCI MAPK6 HCK | 1.79e-05 | 434 | 269 | 17 | CID000005262 |
| Drug | AC1L63MU | DHDDS GRK2 GRK3 CLCNKA ADCY4 FPR1 GRM1 GRM5 GRM7 GRM8 TGFBI GYS2 PRKCD PRKCI MAPK6 | 1.80e-05 | 347 | 269 | 15 | CID000285703 |
| Drug | baclofen | 1.81e-05 | 191 | 269 | 11 | CID000002284 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | PDE1C PDE1B ITGA2B RYR1 RYR2 RYR3 GRK2 GRK3 PKM HSP90AB1 ADCY4 POLR3B GUCY1B1 PDE8B NT5C2 SMARCA4 PRKCD PRKCI MAPK6 HDAC2 | 1.93e-05 | 577 | 269 | 20 | CID000000295 |
| Drug | AC1L1D8L | 2.07e-05 | 71 | 269 | 7 | CID000002241 | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | ABCA2 EVPL CLSTN2 ARHGEF11 ACOX3 NEK1 ABCD1 DOCK1 LMCD1 IPO9 PCNX1 | 2.09e-05 | 194 | 269 | 11 | 5268_DN |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | EPHB4 DHDDS ARHGEF11 MAGEF1 GANAB PLCD1 POLG ADGRL1 MLH3 PDE8B TOP3A | 2.09e-05 | 194 | 269 | 11 | 1146_UP |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | FASTKD5 ARHGEF11 ACOX3 NEK1 ABCD1 SLC25A17 POLG NDST2 OGDH APPL1 TOP3A | 2.19e-05 | 195 | 269 | 11 | 1649_DN |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; PC3; HT_HG-U133A | SPEG GIT2 TUBGCP2 ARHGEF11 MAGEF1 HSF1 EGFR GUCY1B1 PKP3 EPB41L2 PSD4 | 2.30e-05 | 196 | 269 | 11 | 4497_DN |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A | ABCA2 MORN1 ADAM20 SPEG ADGRB2 RYR1 PLCD1 HSF1 EGFR PCNX1 FBXO21 | 2.30e-05 | 196 | 269 | 11 | 6416_UP |
| Disease | cancer (implicated_via_orthology) | SRC PSMC5 DHDDS TRIP12 BRAF FGR NIPBL ALK HSP90AB1 LCK CBX6 MTOR SMARCA4 HCK | 1.66e-07 | 268 | 265 | 14 | DOID:162 (implicated_via_orthology) |
| Disease | Schizophrenia | DYM MAOB MYO5B FASTKD5 ARHGEF11 KCNH6 SYN2 ALDH3A1 ALK DDR1 ANK3 IDE GRM1 GRM5 LHX6 GRM7 GRM8 MTOR SLC6A5 DAAM2 HTR3B MYO16 GABBR1 HDAC2 RASD2 | 4.87e-07 | 883 | 265 | 25 | C0036341 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.16e-07 | 3 | 265 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.16e-07 | 3 | 265 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 9.29e-06 | 32 | 265 | 5 | DOID:10155 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 2.40e-05 | 64 | 265 | 6 | DOID:305 (implicated_via_orthology) | |
| Disease | Attention Deficit Disorder | 4.10e-05 | 22 | 265 | 4 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 4.10e-05 | 22 | 265 | 4 | C1321905 | |
| Disease | Gastric Adenocarcinoma | 5.12e-05 | 45 | 265 | 5 | C0278701 | |
| Disease | margarate 17:0 measurement | 5.78e-05 | 9 | 265 | 3 | EFO_0021066 | |
| Disease | Attention deficit hyperactivity disorder | 5.87e-05 | 24 | 265 | 4 | C1263846 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.24e-05 | 195 | 265 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | X-linked nonsyndromic deafness (implicated_via_orthology) | 8.04e-05 | 2 | 265 | 2 | DOID:0050566 (implicated_via_orthology) | |
| Disease | Arts syndrome (implicated_via_orthology) | 8.04e-05 | 2 | 265 | 2 | DOID:0050647 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 1.24e-04 | 54 | 265 | 5 | C0149925 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.45e-04 | 30 | 265 | 4 | DOID:14330 (biomarker_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.45e-04 | 30 | 265 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 2.28e-04 | 227 | 265 | 9 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 2.34e-04 | 96 | 265 | 6 | C1319315 | |
| Disease | Charcot-Marie-Tooth disease X-linked recessive 5 (implicated_via_orthology) | 2.40e-04 | 3 | 265 | 2 | DOID:0110210 (implicated_via_orthology) | |
| Disease | Grand Mal Status Epilepticus | 3.45e-04 | 67 | 265 | 5 | C0311335 | |
| Disease | Petit mal status | 3.45e-04 | 67 | 265 | 5 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.45e-04 | 67 | 265 | 5 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 3.45e-04 | 67 | 265 | 5 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.45e-04 | 67 | 265 | 5 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.45e-04 | 67 | 265 | 5 | C0751523 | |
| Disease | Status Epilepticus | 3.70e-04 | 68 | 265 | 5 | C0038220 | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 4.76e-04 | 4 | 265 | 2 | C0410204 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 4.76e-04 | 4 | 265 | 2 | C4551898 | |
| Disease | kidney disease (implicated_via_orthology) | 4.96e-04 | 41 | 265 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | worry measurement | 5.04e-04 | 154 | 265 | 7 | EFO_0009589 | |
| Disease | Prescription Drug Abuse | 6.16e-04 | 115 | 265 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 6.16e-04 | 115 | 265 | 6 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 6.16e-04 | 115 | 265 | 6 | C0029231 | |
| Disease | Drug habituation | 6.16e-04 | 115 | 265 | 6 | C0013170 | |
| Disease | Drug abuse | 6.16e-04 | 115 | 265 | 6 | C0013146 | |
| Disease | Drug Use Disorders | 6.16e-04 | 115 | 265 | 6 | C0013222 | |
| Disease | Drug Dependence | 6.16e-04 | 115 | 265 | 6 | C1510472 | |
| Disease | Substance Dependence | 6.16e-04 | 115 | 265 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 6.16e-04 | 115 | 265 | 6 | C0038586 | |
| Disease | Substance abuse problem | 6.45e-04 | 116 | 265 | 6 | C0740858 | |
| Disease | Adenocarcinoma of prostate | 7.29e-04 | 20 | 265 | 3 | C0007112 | |
| Disease | Alcoholic Intoxication, Chronic | 7.58e-04 | 268 | 265 | 9 | C0001973 | |
| Disease | Cetuximab response | 7.89e-04 | 5 | 265 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 7.89e-04 | 5 | 265 | 2 | cv:CN077999 | |
| Disease | beverage consumption measurement | 9.23e-04 | 83 | 265 | 5 | EFO_0010088 | |
| Disease | initial pursuit acceleration | 1.14e-03 | 87 | 265 | 5 | EFO_0008434 | |
| Disease | intercellular adhesion molecule 2 measurement | 1.18e-03 | 6 | 265 | 2 | EFO_0008163 | |
| Disease | Metastatic melanoma | 1.41e-03 | 54 | 265 | 4 | C0278883 | |
| Disease | visceral adipose tissue measurement | PDE1C ARPP21 ADGRB2 TRIP12 EFR3A ABCD1 CAMK1D DNAH10 PARD3B IGF2BP1 IPO9 MTOR | 1.47e-03 | 481 | 265 | 12 | EFO_0004765 |
| Disease | pulse pressure measurement, anxiety | 1.64e-03 | 7 | 265 | 2 | EFO_0005230, EFO_0005763 | |
| Disease | muscular atrophy (implicated_via_orthology) | 1.64e-03 | 7 | 265 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | Colorectal cancer | 1.79e-03 | 27 | 265 | 3 | cv:C0346629 | |
| Disease | Neoplasm of the large intestine | 1.79e-03 | 27 | 265 | 3 | cv:C0009404 | |
| Disease | COLORECTAL CANCER | 1.79e-03 | 27 | 265 | 3 | 114500 | |
| Disease | Sezary Syndrome | 1.79e-03 | 27 | 265 | 3 | C0036920 | |
| Disease | urate measurement, spine bone mineral density | 1.84e-03 | 58 | 265 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | Mental Depression | 2.20e-03 | 254 | 265 | 8 | C0011570 | |
| Disease | neurotic disorder | 2.21e-03 | 101 | 265 | 5 | EFO_0004257 | |
| Disease | Osteoporosis, Age-Related | 2.22e-03 | 61 | 265 | 4 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 2.22e-03 | 61 | 265 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 2.22e-03 | 61 | 265 | 4 | C0029459 | |
| Disease | body weight | CDK17 PDE1C EPHA6 TRIP12 EFR3A NAA25 FNIP1 FGR PRMT7 NIPBL DOCK1 KSR2 PARD3B GRM7 ADAMTS10 IPO9 MTOR ASL XXYLT1 NEK11 EPB41L2 EPHB1 | 2.42e-03 | 1261 | 265 | 22 | EFO_0004338 |
| Disease | Unipolar Depression | 2.48e-03 | 259 | 265 | 8 | C0041696 | |
| Disease | Osteoporosis | 2.50e-03 | 63 | 265 | 4 | C0029456 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.67e-03 | 31 | 265 | 3 | C1335167 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.70e-03 | 206 | 265 | 7 | C0152013 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 2.77e-03 | 9 | 265 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | response to antineoplastic agent, response to anthracycline-based chemotherapy | 2.77e-03 | 9 | 265 | 2 | EFO_0005257, GO_0097327 | |
| Disease | Colon Carcinoma | 2.77e-03 | 9 | 265 | 2 | C0699790 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.77e-03 | 9 | 265 | 2 | C0085548 | |
| Disease | glioblastoma multiforme | 2.77e-03 | 9 | 265 | 2 | EFO_0000519 | |
| Disease | Carcinoma, Small Cell | 2.77e-03 | 9 | 265 | 2 | C0262584 | |
| Disease | gallbladder neoplasm | 2.77e-03 | 9 | 265 | 2 | EFO_0004606 | |
| Disease | Large cell carcinoma of lung | 2.93e-03 | 32 | 265 | 3 | C0345958 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.94e-03 | 156 | 265 | 6 | C0007131 | |
| Disease | obesity (implicated_via_orthology) | 3.42e-03 | 215 | 265 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | visual epilepsy (implicated_via_orthology) | 3.49e-03 | 34 | 265 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | neuroticism measurement | PDE1C ARPP21 AREL1 SYN2 DLST SLC25A17 DOCK3 DOCK8 MYO1H KSR2 GRM5 GRM8 CCDC61 NT5C2 EPB41L2 GABBR1 EPHB1 | 3.74e-03 | 909 | 265 | 17 | EFO_0007660 |
| Disease | Malignant neoplasm of prostate | RGMB NDST4 CHD3 GNMT BRAF CIZ1 HSP90AB1 DDR1 NDST2 SESN3 EGFR EHHADH PKP3 | 4.04e-03 | 616 | 265 | 13 | C0376358 |
| Disease | Prostatic Neoplasms | RGMB NDST4 CHD3 GNMT BRAF CIZ1 HSP90AB1 DDR1 NDST2 SESN3 EGFR EHHADH PKP3 | 4.04e-03 | 616 | 265 | 13 | C0033578 |
| Disease | Bipolar Disorder | MAOB GRK3 DNAH8 ANK3 POLG HIP1R GRM5 GRM7 EHHADH PRKCI HTR3B | 4.15e-03 | 477 | 265 | 11 | C0005586 |
| Disease | anxiety | 4.18e-03 | 223 | 265 | 7 | EFO_0005230 | |
| Disease | argininosuccinate measurement | 4.19e-03 | 11 | 265 | 2 | EFO_0010461 | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 4.19e-03 | 11 | 265 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | eosinophil count | CDK17 DHDDS EPX ZNF785 EPS15L1 NAA25 MDN1 SYN2 FNIP1 DLST PLOD1 DOCK3 DCPS ABCB5 FPR1 SESN3 IGF2BP1 WDR6 PDE8B SMARCA4 PCNX1 PRKCI MYO16 GABBR1 | 4.22e-03 | 1488 | 265 | 24 | EFO_0004842 |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 4.60e-03 | 171 | 265 | 6 | DOID:9352 (is_implicated_in) | |
| Disease | intellectual disability (implicated_via_orthology) | 4.69e-03 | 75 | 265 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ACACA SRC PSMC5 CLSTN2 ABCB4 BRAF GPNMB DNAH8 ABCB5 GRM1 PREX2 MLH3 EGFR EPHA7 | 4.75e-03 | 702 | 265 | 14 | C0009402 |
| Disease | Malignant neoplasm of brain | 4.79e-03 | 38 | 265 | 3 | C0153633 | |
| Disease | Mitral valve prolapse, response to surgery | 5.00e-03 | 12 | 265 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Alzheimer disease, dementia | 5.00e-03 | 12 | 265 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | Brain Neoplasms | 5.16e-03 | 39 | 265 | 3 | C0006118 | |
| Disease | obsolete_red blood cell distribution width | PRPSAP1 CCT3 DHDDS TIPRL SNX13 ABCB4 KSR1 SPHK1 MORF4L1 SYN2 QSOX2 HSP90AB1 LPAR5 DOCK8 INPP5E HIP1R TRMT1 FREM3 CAPN11 CBX6 NT5C2 MYO16 | 5.26e-03 | 1347 | 265 | 22 | EFO_0005192 |
| Disease | Squamous cell carcinoma | 5.32e-03 | 124 | 265 | 5 | C0007137 | |
| Disease | parental longevity | ARPP21 ADGRB2 RYR3 NAA25 KSR2 GRM5 IGF2BP1 SMARCA4 TOP3A EPHA7 PSD4 | 5.37e-03 | 494 | 265 | 11 | EFO_0007796 |
| Disease | nicotine dependence | 5.39e-03 | 78 | 265 | 4 | EFO_0003768 | |
| Disease | Lymphoma | 5.54e-03 | 40 | 265 | 3 | C0024299 | |
| Disease | Moyamoya disease | 5.54e-03 | 40 | 265 | 3 | MONDO_0016820 | |
| Disease | asthma (is_marker_for) | 5.69e-03 | 126 | 265 | 5 | DOID:2841 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGMYALRERRVHVTQ | 366 | P62195 | |
| ELLNALRYHMVGRRV | 166 | Q15582 | |
| YLSLREHLAKGQRML | 596 | O60241 | |
| MALVHARILRVFYGA | 296 | Q96EY9 | |
| RDEFAVAMHLVYRAL | 181 | Q9UBC2 | |
| RKTRHVNILLFMGYS | 506 | P15056 | |
| IILGLEHMHNRFVVY | 301 | P35626 | |
| YVFRGVEHAVRVMVS | 11 | Q9Y6R9 | |
| EIALHTNRQYMRGLV | 971 | Q63HQ2 | |
| RTQIRHMKFGAFALY | 221 | O95503 | |
| MIGSALFAVYLHRRL | 36 | P29965 | |
| GSERHLTYIQKIFRM | 136 | O15254 | |
| AYHRVFVNRSLAMEK | 31 | P49902 | |
| RFGGQRYIVHMRVNK | 66 | O43506 | |
| IHRGMAQEERLSRYQ | 316 | O00148 | |
| FYGRAGEILTMRLRH | 756 | Q2M3G0 | |
| AVAYHLIIDNRRIMN | 321 | P54646 | |
| FNVVMRRHPLVYVVS | 231 | O95264 | |
| FAVLMAHREIYQGRI | 841 | O94910 | |
| VQLGLVAFRRHYMIT | 36 | Q9Y276 | |
| DYGRIISARHFQRVM | 281 | P30838 | |
| ASGMRYLATLNFVHR | 751 | Q08345 | |
| LHAMYKARIQDFVRG | 296 | P54840 | |
| QLMEVTVYRRHGRAY | 206 | Q14956 | |
| LNTYMSHAGIRLREA | 476 | O15085 | |
| LVQRYRSGIRGHMKA | 971 | Q13085 | |
| VAYDRAMIHLSRVRG | 1181 | Q9ULD4 | |
| MGLEAFHLYLLAVRV | 356 | Q86Y34 | |
| VAGVYHKALMERALR | 186 | Q8NFM4 | |
| FIRAKYQMLAFVHRL | 106 | Q14161 | |
| AMRAHAAALGVQDYL | 411 | Q3MIX3 | |
| MVHGNERFIQYLASR | 86 | O60641 | |
| MSRIYHDGALRNKAV | 1 | Q7Z6K5 | |
| GMAHVLVVYRVLASA | 346 | A1A5B4 | |
| VHYRGKMETLIRVRN | 306 | Q9UMQ6 | |
| FVVAMGVYRVRIAHQ | 846 | Q9H4D0 | |
| EIHNLGRFITVMKFR | 231 | Q14692 | |
| AILQRYRMKGDHLRV | 251 | Q96C86 | |
| LDKGQLRIHRDGIYM | 91 | P32970 | |
| RVGRTMHHFGYLLLV | 581 | A7MBM2 | |
| VVRHRSGYVLIAMEA | 66 | Q14156 | |
| RMLVHRVAAYFGLDH | 196 | Q9UBL0 | |
| MVAYHGRRDVEQYVL | 251 | Q9H324 | |
| TEFYVMEHVQGRIFR | 116 | Q709F0 | |
| IILGLEHMHNRFVVY | 301 | P25098 | |
| LMREIHARFGNLSLY | 5101 | Q9HC84 | |
| AVLQTMRRYVHTFFG | 461 | Q6ZRP7 | |
| QVQLRYLLHIFMEAG | 1261 | Q4ADV7 | |
| AVINMYGRLIHRVRY | 326 | A0A1B0GVH7 | |
| VYRIARQASRMGNHD | 526 | Q9NVH2 | |
| EFVHLGAIDMYLRKR | 601 | P52333 | |
| LFRARPVQIAVYHML | 1391 | O94822 | |
| HLLRLFVRIGAMLAY | 301 | Q9UBU8 | |
| KGELRYMHSRVVANS | 276 | P33897 | |
| DYREVHQMIRELAIG | 96 | Q7Z5J8 | |
| NYAAIMGFILAHKAR | 336 | P27338 | |
| QAAAAHLGEYVLMIR | 426 | Q5T089 | |
| GYHTKARAVMNFVVR | 641 | O60568 | |
| FRLHLRYEFLMLGIQ | 296 | Q86T65 | |
| FINRRGAHRIYTEMR | 76 | P54762 | |
| LNLYMHQVLIRRTGI | 286 | O94952 | |
| HNLRFEGMERQYASL | 1071 | Q8TEW8 | |
| AVASHYMRQILEALR | 116 | O14936 | |
| HSNRIYRMIKLGLGI | 676 | P08238 | |
| VRILQMVADGIRYLH | 161 | Q96QS6 | |
| MVADGIRYLHALQIT | 166 | Q96QS6 | |
| VRVKAYYRGDIMITH | 26 | P41743 | |
| QHVFLVYGERMRTEE | 1971 | Q9NU22 | |
| VLGLSQFAHYRRKQM | 21 | P43304 | |
| REQYGIQRVEAMLHT | 61 | P41594 | |
| ALYQRRHTAGMLALS | 151 | Q9GZN0 | |
| HRVVLAAASNYFRAM | 86 | Q8WZ60 | |
| EMLRRLGVQPSKYHF | 191 | Q9HAY2 | |
| GGREYLRQIYHIMQL | 1136 | Q8IV33 | |
| FLMLINVDRYAAIVH | 111 | Q9H1C0 | |
| QNKARAEGHMVYLAR | 546 | Q96PY6 | |
| AEGHMVYLARLRQIR | 551 | Q96PY6 | |
| RDKHLAVAYFQRGML | 66 | P19878 | |
| RGAVHVYATLRFTML | 81 | P54760 | |
| MNYIHRDLRAANILV | 376 | P09769 | |
| AAHGVLYMSLFIRRD | 366 | Q9NRR6 | |
| AHIYEGRVIQIVLMR | 61 | Q05655 | |
| IQYFKGDMIIRRHTI | 716 | Q9Y6X6 | |
| ANLLLVHGERYMAVL | 101 | Q8TDU6 | |
| MAARRALHFVFKVGN | 1 | Q9HC38 | |
| DHRAVGMAIYNVAVL | 801 | Q9UBS5 | |
| GHFYASQMAQRKIRD | 541 | Q9NZI8 | |
| YLVRKGMPFRQAHEA | 376 | P04424 | |
| VMAYRQTRHENVVLF | 711 | Q6VAB6 | |
| VYETMRQILAARAIH | 521 | Q9UKG1 | |
| GTARYHTQMLRVKEF | 521 | Q9H252 | |
| TRVLQMVLDGVRYLH | 196 | P11801 | |
| ARFQLQYMGHYLIRD | 736 | Q8IY21 | |
| ARFQLQYMGHYLIRD | 716 | Q5H9U9 | |
| GRLMYVINNAHRIGV | 406 | Q8N1V2 | |
| RVEGDNIYVRHSNLM | 616 | O43491 | |
| MAEYTRLHNALALIR | 1 | Q08426 | |
| ARNRRFHLIAMDAYQ | 61 | Q70Z53 | |
| RQLNMYGFRKVVHIE | 71 | Q00613 | |
| MVNYRLHRALDAGEV | 76 | Q96RV3 | |
| LYLLHQRVRRFGIMG | 251 | O43808 | |
| YRQTRHENVVLFMGA | 661 | Q8IVT5 | |
| RHFDVALGRMVYVNK | 1046 | Q9UHC1 | |
| EEHARLFMYQLLRGL | 126 | Q16659 | |
| LKQHYFIDRDGQMFR | 71 | Q719H9 | |
| VHAVQAGIFVERMFR | 126 | Q01064 | |
| VHAVQAGIFVERMYR | 131 | Q14123 | |
| GERLQALTLLMIHYR | 1081 | Q8NEN9 | |
| VVRAADYMHVALGLL | 86 | P11678 | |
| NHYRTLRQAIIDMVL | 711 | O95263 | |
| RYSVHKAMERGLIEN | 1876 | Q92817 | |
| RRAGIATFMIYHLIQ | 711 | Q9H8E8 | |
| NLINAIRMIHGVSRY | 261 | Q96JB1 | |
| YLGNLVTVFSRQHMR | 2086 | Q5H8C1 | |
| ALARHRYMKQAQALG | 216 | Q86SU0 | |
| YSMIRGNRQHRRAFL | 2396 | Q6KC79 | |
| AHIREQYLIQGSRMR | 276 | P54098 | |
| QLLLGVDYMHERRIL | 141 | Q8NG66 | |
| GVTAEMQNLVHRRIY | 836 | O60337 | |
| MAENRHLQYERFVVA | 111 | Q6UX53 | |
| RMQHLIAREAEAAIY | 376 | P14618 | |
| GMAFIEERNYIHRDL | 351 | P06239 | |
| RARMVTLHGYIESQV | 311 | Q9UPM6 | |
| AHLRSIKRYFLMDQG | 511 | Q9BSJ2 | |
| MYGFVNHALELLVIR | 1 | Q02153 | |
| SMHNVKLFLYQILRG | 286 | Q00537 | |
| MVRAGGLLVIDHRNY | 166 | Q14749 | |
| VLALRRAHDYEVAQM | 346 | Q9P215 | |
| PARYRKGFIHNSIMV | 456 | Q9H3R1 | |
| MAKNIEDYIHRIGRT | 741 | Q9BUQ8 | |
| MALIVATQFRFRYNH | 381 | Q6ZSS7 | |
| DMGYVHRDLAARNIL | 751 | Q15375 | |
| KGIHRLEAMLYAIDQ | 71 | O00222 | |
| GTEGAFYRRRQLMHQ | 146 | Q9NZU5 | |
| VLYAVFGQHSMRRVI | 461 | Q9P2V4 | |
| FEMGHVRARNLAYDT | 221 | Q02809 | |
| YLIVNGHMRFRDVIL | 961 | P21439 | |
| YRHLLRAMGEHLAQY | 436 | Q9Y6X9 | |
| AFSLAHRRVYQDMGQ | 286 | P51178 | |
| MYVALTYDHRLIDGR | 416 | P36957 | |
| IIRRLEMAYCQHIGV | 206 | Q02218 | |
| ANFREAMRIGAEVYH | 176 | P06733 | |
| IAKGMNYLEDRRLVH | 821 | P00533 | |
| RMREVAAVLLHFKGY | 211 | O00471 | |
| TVLMELGVRFHRLIY | 601 | O00471 | |
| AERMRLGELRKQHYV | 996 | O75146 | |
| AEGMAFIEQRNYIHR | 366 | P08631 | |
| GLHNMKRRQLARLGY | 716 | Q7L8L6 | |
| RGEQRAVRYYSHMKL | 11 | Q8N954 | |
| EIRYRGMLHALVRIG | 46 | Q5SVS4 | |
| MAALAYNLGKREINH | 1 | Q96PB1 | |
| LFHFRYMGKRNIARV | 1321 | Q5JSL3 | |
| LYVQDNREMFRSVRH | 106 | Q14185 | |
| DLYIVAHVIRIGRML | 286 | Q8IZD9 | |
| SLMDRGFVFNLIRHY | 1061 | Q8NF50 | |
| NSFRMLYQRFHKGDV | 421 | Q9Y6W3 | |
| GLLDAGKMYVHRQVR | 191 | P29017 | |
| EVLRQSISHKYLMRG | 191 | Q7RTS9 | |
| HRATVYAQLVESGRM | 176 | Q9NVM4 | |
| VYMGHALYRLRVLEE | 91 | P57773 | |
| HRIGQANKVMIYRFV | 1171 | Q12873 | |
| LSEYLRGQMRVHVKE | 1121 | Q8TF40 | |
| GIRETIRYLVQHNMV | 111 | P49366 | |
| THRIMRDSGLFGQYL | 791 | Q6MZW2 | |
| SVDRYIAIAQAMRAH | 141 | P51686 | |
| HSQLLQYMERYGKRL | 421 | A8MPP1 | |
| FRMRSHSYLRAIQAG | 496 | O95886 | |
| HLKNRFGDGYMITVR | 2271 | Q9BZC7 | |
| TRSFLAQIIGLRMHY | 581 | O15033 | |
| HMAARSGQAEVVRYL | 471 | Q12955 | |
| RYLHSAVLINGAMLI | 521 | Q5VV63 | |
| VHYFDGRKRMILSTI | 301 | Q9NV96 | |
| VAHLDLARMYIEAGN | 341 | P09914 | |
| LARMYIEAGNHRKAE | 346 | P09914 | |
| YIMFSGHLNDNERRV | 1021 | Q96P70 | |
| AQERLQHYFMGRALE | 486 | Q15051 | |
| KRENGIHRLEAMLYA | 71 | Q14831 | |
| IRRIHNGESMAYLFR | 336 | Q14558 | |
| RIHNGESMSYLFRNI | 351 | O60256 | |
| ILHMFQYIQKLRAEG | 391 | P14735 | |
| AYRGLRLHFLVIMRD | 251 | Q49AJ0 | |
| LVIVGLLMFRYHRRG | 176 | Q99075 | |
| FVQGLHLYRMQVEPR | 2621 | Q9NYQ7 | |
| IRMTHNLLLNYGLYR | 36 | Q92769 | |
| REQYGIQRVEAMFHT | 71 | Q13255 | |
| PKHIAFIMDGNRRYA | 26 | Q86SQ9 | |
| HYDFGLRALKSVLVM | 2001 | Q8IVF4 | |
| YDANKRHRVFLLIGM | 146 | Q99500 | |
| LVRAMFSLLHRQYDG | 2116 | P21817 | |
| VRAMFVLLHRQYDGI | 2081 | Q92736 | |
| YQQARLHDRGAAEMV | 3726 | Q92736 | |
| FVRQLNMYGFRKVVH | 61 | Q03933 | |
| DMGYVHRDLAARNIL | 791 | Q9UF33 | |
| IYQHRMLRSGQGDAL | 1231 | P42345 | |
| YHKEVVRLMSGEFRQ | 1046 | Q9Y6R4 | |
| NLVRYFGVELHREEM | 1401 | Q9Y6R4 | |
| YRVGEKILFIRMLHN | 231 | O43903 | |
| LQRDIMEGRLFYRHL | 646 | P0C091 | |
| FQLRAHMYQARGLIA | 826 | Q2WGJ9 | |
| QHYRQTVRALRMEFV | 61 | Q9BYN8 | |
| MYQRGRAVLREAGFH | 256 | Q9HA92 | |
| EDFRHLIIGMQYAGL | 196 | Q92777 | |
| HNQLNRRMVYVFLEG | 911 | Q9Y5W8 | |
| MHARYIGTTVFVRQV | 271 | Q6NW40 | |
| ERMNYVHRDLRAANI | 381 | P12931 | |
| LMYQHQRVSERFDVI | 216 | Q9NXH9 | |
| HDKQRGPLVFMRIYS | 376 | Q969S9 | |
| RGCTLQYQHAMVRVL | 566 | Q14C87 | |
| FLAQHRGERYKNMID | 761 | Q9Y345 | |
| AVQIARGMLYLHEEA | 241 | Q5TCX8 | |
| VVMVGRYFQKRRALA | 146 | Q7RTX9 | |
| RVAYAFLRHRVQFGM | 806 | Q58EX7 | |
| MHTRQTLAIYDRFGR | 216 | Q9BRJ2 | |
| AIRGLHYDVQRAVLM | 146 | Q86UY8 | |
| GLYVHMATADGLRQR | 576 | Q14697 | |
| YVFMGQDFRERLIHA | 301 | P21462 | |
| AVRLGHIQYMSSIVR | 1036 | Q6ZNJ1 | |
| LQMLYVRRVCFFRGH | 271 | A3QJZ6 | |
| NRLKVLFYRGMLDHI | 206 | O94933 | |
| FHTLLRGMVLYFLKQ | 806 | Q8NDX1 | |
| SALQRVLYRHMQAKG | 1001 | P51532 | |
| QHYLMRANITAIRRV | 301 | P49368 | |
| HLRQQRMGTYGVRAA | 251 | P13598 | |
| QRLHRLRGEQMASYF | 306 | P08514 | |
| SAIIFMYARPRVIHA | 251 | O95007 | |
| RQVLDAVYYLHRMGI | 126 | Q8IU85 | |
| AVYYLHRMGIVHRDL | 131 | Q8IU85 | |
| LAVAYHLIIDNRRIM | 331 | Q13131 | |
| AFSGIMIVYRRKHQE | 1051 | Q9UM73 | |
| IHYRLVMRRLGVAAL | 101 | E9PGG2 | |
| KTDNLVNHRLIGMAY | 846 | Q13733 | |
| LLQHVERLYGMVRAE | 416 | Q9H6Q4 | |
| VTLVQMNHAAARRFY | 541 | Q86XI2 | |
| HLSVMIAAYLGRVRT | 171 | P51800 | |
| LGAVFVYLHRQVMLG | 361 | P35523 | |
| RVEARKTYMGLRNHF | 271 | O75122 | |
| LYYMGDLIQHRRTQD | 661 | Q9ULV3 | |
| EVQRHATGAMRNLIY | 376 | Q9Y446 | |
| VRGFRVAYKRHVLTM | 376 | Q9H4L4 | |
| MHRAELQRARALQSY | 221 | Q5TAP6 | |
| IRAYMRQVLEGIHYL | 1696 | Q15772 | |
| MNALFRGVFVHRYRD | 301 | Q9UJ98 | |
| YQQARLHERGAAEMV | 3616 | Q15413 | |
| GARVVRTLTVQYRMH | 431 | P38935 | |
| IGHLLDEKFRMVYNL | 371 | P58005 | |
| MQAELLYALRAITRH | 476 | P58005 | |
| GVLIRMNDTRLYHEA | 191 | O75663 | |
| FGYVTFMHLEALRQR | 471 | Q9Y4K3 | |
| RVQHQGDLIRERSYM | 226 | Q9Y2P7 | |
| FMAKRIHAEGLGYRV | 416 | O75191 | |
| MGVRVHVVAASALLY | 1 | Q4KMG9 | |
| RYQLTMHQRIYSGEK | 321 | Q96SK3 | |
| ARYRRGFIHNGIMVL | 466 | P52849 | |
| HRKVYNIRGDMYQLD | 56 | Q96D21 | |
| GHRYLFRGRINTEVM | 291 | Q70Z35 | |
| MAVKQGRFYLRHNTL | 216 | Q9NW08 | |
| VYSLDFGGHLRMIKR | 41 | Q9NNW5 | |
| SRQLYVLGHEAMKRL | 56 | P22314 | |
| VAHGLMILARNYLDV | 466 | Q13472 | |
| SMQRLALILHQLGRY | 766 | Q86TV6 | |
| GLSQVEYALRRHKLM | 66 | Q9NQH7 | |
| QRILYRDVMLETFGH | 46 | P17098 | |
| HLFYVRAGVSRAMLL | 286 | Q9NYA1 | |
| RIISMLNYFLQHLVG | 876 | Q14139 | |
| AMSKVRRLHYEGLIF | 416 | Q5T9L3 | |
| AYEGMLAHQREKIRA | 101 | Q2TAA8 | |
| IFSVYFRREGVMHQV | 916 | Q14669 | |
| YLMLRAVDRFHKQQG | 426 | Q13564 | |
| VMLENYRHLVFLGII | 41 | Q96H40 | |
| LDMYGISARHIIVAV | 576 | P51854 | |
| YMLVVHGRAIRQLKR | 236 | Q9H1B5 | |
| HYLMQLNRLAGRRQG | 361 | Q562E7 | |
| RALYRDVMRETFGHL | 51 | A8K8V0 | |
| IGIAREMQPVYRHTF | 251 | Q8NBI6 | |
| GLLDTAQRALYRHVM | 16 | Q6AW86 | |
| AQRALYRHVMLENFT | 21 | Q6AW86 | |
| RLRVAKESGYNMIHF | 146 | P35573 | |
| YHSMAAVQRKLYVLG | 486 | Q96NJ5 | |
| LMEHLRVRRAGFAYR | 621 | Q8N1T3 | |
| IGFDKRYHIIGANMR | 226 | Q9ULV0 | |
| RYHIIGANMRTYLLE | 231 | Q9ULV0 | |
| LSVVRELMLRYQHGL | 436 | Q14CX7 | |
| TKGHIQMFERARDYL | 21 | Q9BZQ4 | |
| QMFERARDYLHKTGR | 26 | Q9BZQ4 |